Herpesviral [herpes simplex] infections

AB1_HERPES_SIMPLEX

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B00 Hospital discharge: ICD-9 — 05[4] Hospital discharge: ICD-8 — 05[4] Hospital discharge: excluded ICD-9 — 0541A Hospital discharge: excluded ICD-8 — 0540[2] Cause of death: ICD-10 — B00 Cause of death: ICD-9 — 05[4] Cause of death: ICD-8 — 05[4] Cause of death: excluded ICD-9 — 0541A Cause of death: excluded ICD-8 — 0540[2] 2 out of 7 registries used, show all original rules.	4867
4. Check minimum number of events None	4867
5. Include endpoints None	4867
6. Filter based on genotype QC (FinnGen only)	4867

Control definitions (FinnGen only)

Control exclude: AB1_VIRAL_SKIN_MUCOUS_MEMBRANE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_HERPES_SIMPLEX
CONTROL_EXCLUDE	AB1_VIRAL_SKIN_MUCOUS_MEMBRANE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B00
HD_ICD_9	05[4]
HD_ICD_8	05[4]
HD_ICD_10_EXCL
HD_ICD_9_EXCL	0541A
HD_ICD_8_EXCL	0540[2]
COD_MAINONLY
COD_ICD_10	B00
COD_ICD_9	05[4]
COD_ICD_8	05[4]
COD_ICD_10_EXCL
COD_ICD_9_EXCL	0541A
COD_ICD_8_EXCL	0540[2]
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Herpesviral [herpes simplex] infections based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Explicit viral Sepsis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	37387	21787	15388
Only index persons	33592	20093	13499
Unadjusted period prevalence (%)
Whole population	0.54	0.62	0.43
Only index persons	0.65	0.74	0.52
Median age at first event (years)
Whole population	41.45	42.64	39.62
Only index persons	40.80	42.22	38.70

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4867	3228	1639
Unadjusted period prevalence (%)	0.97	1.10	0.72
Median age at first event (years)	48.60	46.03	53.68

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4343: Matched controls
43428

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S01AD03

ATC

aciclovir; ophthalmic

59.1

323.0

1688

462

J05AB01

ATC

aciclovir; systemic

11.0

323.0

2611

5248

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

220.7

323.0

437

J05AB11

ATC

valaciclovir; oral

8.9

323.0

1652

2790

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

+∞

323.0

480

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

+∞

323.0

1178

B00.11

ICD-10 Finland

Herpes simplex labialis

33.3

323.0

468

157

B00.10

ICD-10 Finland

Herpes simplex facialis

115.7

323.0

564

B00.5

ICD-10 Finland

Herpesviral ocular disease

346.0

287.5

288

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

175.3

267.5

279

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

70.8

226.3

260

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

87.9

201.5

225

H13.1*B00.5

ICD-10 Finland

Herpesviral conjunctivitis

+∞

158.3

151

D06BB03

ATC

aciclovir; topical

5.5

152.1

484

963

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.4

150.1

2016

11649

05405

ICD-8 Finland

Herpes simplex, Kerato-conjunctivitis herpetica

+∞

128.8

123

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

25.6

128.4

182

H16.9

ICD-10 Finland

Keratitis, unspecified

11.1

126.4

248

235

05401

ICD-8 Finland

Herpes simplex, Gingivostomatitis

+∞

123.5

118

B00.0

ICD-10 Finland

Eczema herpeticum

31.3

119.2

160

H16.0

ICD-10 Finland

Corneal ulcer

5.0

114.4

397

862

B02.9

ICD-10 Finland

Zoster without complication

6.0

112.5

330

588

H02AB06

ATC

prednisolone; systemic

2.1

110.7

2155

14026

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

+∞

108.8

104

L20.0

ICD-10 Finland

Besnier prurigo

3.6

100.0

493

1482

H04.10

ICD-10 Finland

Dry eye syndrome

3.1

99.9

612

2167

H19.2*B02.3

ICD-10 Finland

Keratitis and keratoconjunctivitis (interstitial) in zoster

969.7

97.4

H22.0*B00.5

ICD-10 Finland

Herpesviral iridocyclitis

+∞

87.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

87.7

1814

11713

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

8.5

85.8

195

240

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

2.0

82.7

1495

9118

J01DB01

ATC

cefalexin; oral

2.1

81.8

3592

30122

B00.8

ICD-10 Finland

Other forms of herpesviral infection

75.8

78.4

H03.1*B02.3

ICD-10 Finland

Zoster blepharitis

+∞

78.4

G02.0*B00.3

ICD-10 Finland

Herpesviral meningitis

+∞

78.4

D07AA02

ATC

hydrocortisone; topical

2.4

77.4

752

3473

0542A

ICD-9 Finland

Herpes simplex, Herpetic gingivostomatitis[GINGIVOSTOMATITIS HERPETICA]

+∞

75.2

E0000UV

ATC

1.8

72.8

1797

12099

B02.3

ICD-10 Finland

Zoster ocular disease

243.9

70.5

H03.1

ICD-10 Finland

Involvement of eyelid in other infectious diseases classified elsewhere

84.8

67.1

R50.9

ICD-10 Finland

Fever, unspecified

2.3

66.6

686

3237

E000001

ATC

2.0

64.7

993

5579

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.5

63.4

555

2406

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

4.1

63.3

260

660

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

62.6

773

3960

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

3.2

61.9

356

1187

D11AH01

ATC

tacrolimus; topical

9.7

61.4

128

136

E000002

ATC

2.3

58.4

597

2793

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

57.6

453

1845

D07AC01

ATC

betamethasone; topical

1.7

54.7

1449

9726

D11AX14

ATC

[U] tacrolimus; topical

14.4

53.7

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.2

53.5

608

2983

S71

ICPC

Herpes simplex

10.5

51.4

102

S01GX01

ATC

cromoglicic acid; ophthalmic

1.9

51.4

936

5540

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.8

50.1

225

618

N03AX16

ATC

pregabalin; oral

1.8

49.6

989

6026

127

Kela drug reimbursment

Transplant complication

7.6

48.9

118

160

B00.4

ICD-10 Finland

Herpesviral encephalitis

483.1

48.4

R06AE07

ATC

cetirizine; oral

1.6

48.4

1895

14054

D07AB08

ATC

desonide; topical

2.2

47.8

520

2493

L04AD01

ATC

ciclosporin; systemic

5.9

47.6

137

237

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

9.8

47.6

102

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

6.7

47.6

125

192

0541B

ICD-9 Finland

Herpes simplex, Genital herpes[HERPES GENITALIS RECIDIVANS]

+∞

46.9

05403

ICD-8 Finland

Herpes simplex, Cutaneus (Eczema herpeticum)

+∞

46.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

46.4

438

1959

A02BC02

ATC

pantoprazole; systemic

1.6

45.2

2610

21193

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

45.0

1211

8062

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

44.4

775

4488

R03AC02

ATC

salbutamol; inhalant

1.6

43.5

2200

17218

J01FF01

ATC

clindamycin; systemic

1.7

43.3

1118

7338

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

43.1

1507

10752

TAB00

NOMESCO Finland

Lumbar puncture

3.1

42.8

244

806

J01DA01

ATC

[U] cefalexin; systemic

1.6

42.7

2621

21441

L04AA06

ATC

mycophenolic acid; systemic

6.2

41.1

114

189

N02AX02

ATC

tramadol; systemic, rectal

1.6

40.9

1649

12152

H57.1

ICD-10 Finland

Ocular pain

3.6

40.8

191

543

H01.0

ICD-10 Finland

Blepharitis

2.8

40.2

280

1055

B02.8

ICD-10 Finland

Zoster with other complications

25.8

40.2

A87.9

ICD-10 Finland

Viral meningitis, unspecified

10.6

40.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

40.1

1126

7539

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

39.9

461

2260

D07AC13

ATC

mometasone; topical

1.6

39.7

1209

8274

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

39.6

1869

14267

H02AB04

ATC

methylprednisolone; systemic

1.9

39.2

621

3457

H02AB07

ATC

prednisone; oral

1.9

38.8

607

3364

05400

ICD-8 Finland

Herpes simplex, Labialis

+∞

38.6

H22.0*B02.3

ICD-10 Finland

Zoster iridocyclitis

+∞

38.6

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

38.1

466

2342

L04AA01

ATC

[U] ciclosporin; systemic

6.0

37.8

107

182

N05BB01

ATC

hydroxyzine; systemic

2.5

37.6

317

1330

0540A

ICD-9 Finland

Herpes simplex, Eczema herpeticum

+∞

37.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

37.1

2099

16609

R51.80

ICD-10 Finland

Headache

1.9

37.0

651

3757

ZX120

NOMESCO Finland

Intravenous

2.2

36.6

411

1988

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

35.8

807

5041

D07CC01

ATC

betamethasone and antibiotics; topical

1.9

35.4

560

3110

WW500

NOMESCO Finland

Blood transfusion

3.2

35.0

196

640

D70.82

ICD-10 Finland

Drug-induced neutropenia

5.3

35.0

110

213

F29

ICPC

Eye symptom/complaint other

2.2

34.5

362

1697

N02BE01

ATC

paracetamol; systemic, rectal

1.6

34.4

3535

31699

L04AX01

ATC

azathioprine; systemic

2.9

34.1

219

784

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

34.0

836

5351

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.1

34.0

191

625

AA1AD

NOMESCO Finland

CT of head and brain

1.7

34.0

857

5528

XQ800

NOMESCO Finland

Prick test

2.2

34.0

370

1762

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

33.7

687

4153

J02AC01

ATC

fluconazole; systemic

1.5

33.3

1711

13142

F01

ICPC

Eye pain

3.6

33.2

156

446

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.5

32.8

267

1101

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

32.6

543

3066

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

31.7

1204

8615

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

2.4

31.5

288

1261

N03AX12

ATC

gabapentin; oral

1.8

31.3

613

3653

H16.2

ICD-10 Finland

Keratoconjunctivitis

8.6

31.1

R06AX13

ATC

loratadine; oral

1.7

30.8

671

4131

XW000

NOMESCO Finland

Bone marrow biopsy

3.0

30.7

187

644

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

30.3

214

813

N02AA05

ATC

oxycodone; systemic

1.9

30.3

520

2963

D11AX15

ATC

[U] pimecrolimus; topical

17.6

30.1

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

29.9

330

1579

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

29.9

841

5567

A86

ICD-10 Finland

Unspecified viral encephalitis

12.1

29.6

J01MA12

ATC

levofloxacin; systemic

1.7

29.5

681

4262

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

29.4

449

2453

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.8

29.2

553

3252

R06.0

ICD-10 Finland

Dyspnoea

1.6

29.2

915

6223

S01FA04

ATC

cyclopentolate; ophthalmic

6.6

29.1

117

J01MA02

ATC

ciprofloxacin; systemic

1.5

29.0

1459

11065

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.9

28.8

423

2277

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

2.4

28.7

264

1158

J01FA10

ATC

azithromycin; systemic

1.4

28.6

2388

19988

J01FA06

ATC

roxithromycin; oral

1.5

28.4

1606

12459

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

28.2

356

1803

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

28.2

1781

14117

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.5

27.9

135

396

D02AX

ATC

Other emollients and protectives

2.9

27.6

172

605

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

27.5

234

988

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

4.1

27.3

108

267

H20.1

ICD-10 Finland

Chronic iridocyclitis

6.3

27.0

118

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

26.7

519

3074

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.3

26.5

260

1179

J01CA04

ATC

amoxicillin; systemic

1.5

26.4

3337

30014

E000006

ATC

2.1

26.4

314

1551

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

26.3

894

6184

C03CA01

ATC

furosemide; systemic

1.6

26.1

890

6156

J01AA02

ATC

doxycycline; systemic

1.4

26.1

3101

27500

A46

ICD-10 Finland

Erysipelas

1.8

26.1

474

2746

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.8

26.0

170

615

J05AB09

ATC

famciclovir; oral

8.3

26.0

TQW80

NOMESCO Finland

Local dermatologic skincare

3.4

25.9

131

398

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

25.7

1158

8527

XQ802

NOMESCO Finland

Epicutan test

2.5

25.4

202

823

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

25.3

681

4435

UJF32

NOMESCO Finland

Coloscopy

1.5

25.3

927

6520

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

25.2

744

4961

R42

ICD-10 Finland

Dizziness and giddiness

1.6

25.1

783

5295

H62.1*B00.19

ICD-10 Finland

Otitis externa in herpesviral [herpes simplex] infection

+∞

25.0

0544B

ICD-9 Finland

Herpes simplex, With ophthalmic complications[KERATITIS DENDRITICA, HERPETICA]

+∞

25.0

R06AE09

ATC

levocetirizine; oral

1.7

24.8

594

3743

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

24.8

673

4391

J01MA14

ATC

moxifloxacin; systemic

2.0

24.8

340

1779

B07.9

ICD-10 Finland

Verruca simplex

3.6

24.7

112

313

L03AA02

ATC

filgrastim; parenteral

3.2

24.6

131

414

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

2.3

24.6

242

1099

S01AX11

ATC

[U] ofloxacin; ophthalmic

2.8

24.5

162

591

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

24.2

439

2536

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.9

24.2

377

2068

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.9

24.2

408

2301

0549X

ICD-9 Finland

Herpes simplex without mention of complication

+∞

24.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

23.9

1264

9590

G53.0*B02.20

ICD-10 Finland

Trigeminal neuralgia after shingles

125.7

23.6

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

23.4

361

1972

C01CA24

ATC

epinephrine; parenteral

2.1

23.4

283

1407

A07AA02

ATC

nystatin; oral

2.2

23.3

248

1166

B02

ICD-10 Finland

Zoster [herpes zoster]

2.8

23.2

151

547

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

23.2

795

5488

Z94.0

ICD-10 Finland

Kidney transplant status

5.9

23.0

112

A02BC05

ATC

esomeprazole; systemic

1.4

23.0

1523

12038

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

5.0

23.0

149

05407

ICD-8 Finland

Herpes simplex, Suspectus

+∞

22.9

D02AE01

ATC

carbamide; topical

2.0

22.9

288

1454

S01ED01

ATC

timolol; ophthalmic

2.9

22.9

142

497

R06AX27

ATC

desloratadine; oral

1.5

22.8

1102

8200

R01AD09

ATC

mometasone; nasal

1.4

22.8

1794

14616

L20

ICD-10 Finland

Atopic dermatitis

3.0

22.7

132

444

M79.6

ICD-10 Finland

Pain in limb

1.4

22.6

1332

10293

H16.3

ICD-10 Finland

Interstitial and deep keratitis

40.3

22.6

G05.1

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere

231.1

22.6

WW200

NOMESCO Finland

Immunization

3.1

22.5

129

429

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.9

22.4

138

483

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.1

22.4

222

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.8

22.2

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

22.1

399

2303

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

5.9

21.8

104

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

21.7

185

782

S01ED51

ATC

timolol, combinations; ophthalmic

2.1

21.7

251

1225

H10

ICD-10 Finland

Conjunctivitis

2.1

21.4

251

1234

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

21.3

279

1434

6BA02

NOMESCO Finland

18.9

21.2

A02BC01

ATC

omeprazole; systemic

1.5

21.2

1007

7447

H17.1

ICD-10 Finland

Other central corneal opacity

15.6

21.0

5AB01

NOMESCO Finland

24.3

20.8

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

20.8

865

6218

E000003

ATC

2.2

20.7

207

946

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

20.5

1069

8040

S18

ICPC

Laceration/cut

1.4

20.5

1466

11681

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

20.4

1532

12305

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.4

20.4

170

711

E000007

ATC

2.1

20.4

250

1251

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

20.3

836

5989

P01AB01

ATC

metronidazole; oral, rectal

1.4

20.3

1533

12321

H02AB09

ATC

hydrocortisone; systemic

3.2

20.3

110

354

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

19.9

1383

10955

05406

ICD-8 Finland

Herpes simplex, alius

+∞

19.8

D11AH02

ATC

pimecrolimus; topical

7.6

19.8

ZXA10

NOMESCO Finland

Bilateral

1.5

19.8

660

4511

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.9

19.7

125

446

G44.2

ICD-10 Finland

Tension-type headache

1.6

19.7

516

3320

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.5

19.7

159

655

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

7.0

19.6

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

19.6

474

2986

TGC00

NOMESCO Finland

Bronchial lavation

3.1

19.4

106

343

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.9

19.4

303

1662

Z71.8

ICD-10 Finland

Other specified counselling

1.5

19.3

911

6708

H13.1

ICD-10 Finland

Conjunctivitis in infectious and parasitic diseases classified elsewhere

31.4

19.2

H18.8

ICD-10 Finland

Other specified disorders of cornea

6.3

19.2

R03BA05

ATC

fluticasone; inhalant

1.5

19.1

689

4792

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

19.0

549

3621

R03BA02

ATC

budesonide; inhalant

1.5

19.0

668

4620

WX110

NOMESCO Finland

Local anesthesy

1.3

19.0

2712

24013

JN4BD

NOMESCO Finland

Extensive body CT

1.8

18.8

372

2205

Z94.7

ICD-10 Finland

Corneal transplant status

9.6

18.8

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.3

18.8

291

M04AA01

ATC

allopurinol; systemic

1.7

18.8

379

2264

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

18.8

602

4075

H10.5

ICD-10 Finland

Blepharoconjunctivitis

3.6

18.7

234

ZX108

NOMESCO Finland

Inhalation

6.2

18.7

D07AD01

ATC

clobetasol; topical

1.6

18.4

561

3748

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.4

18.2

271

H17.8

ICD-10 Finland

Other corneal scars and opacities

13.6

18.2

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

18.2

342

1996

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

18.1

676

4734

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.5

18.0

145

597

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

3.2

17.9

297

JN4AD

NOMESCO Finland

Body CT examination

1.9

17.8

258

1378

R03DC03

ATC

montelukast; oral

1.5

17.8

615

4230

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

17.8

450

2865

05409

ICD-8 Finland

Herpes simplex, Unspecified

+∞

17.7

R01AD08

ATC

fluticasone; nasal

1.4

17.6

1079

8326

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

17.4

320

1854

M54.5

ICD-10 Finland

Low back pain

1.4

17.4

1224

9660

TK800

NOMESCO Finland

Hemodialysis

3.3

17.4

265

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.9

17.3

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

3.1

17.3

316

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

13.9

17.2

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.0

17.2

220

1119

G03.9

ICD-10 Finland

Meningitis, unspecified

11.1

17.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

17.1

375

2293

M25.5

ICD-10 Finland

Pain in joint

1.4

17.0

1046

8064

H17.9

ICD-10 Finland

Corneal scar and opacity, unspecified

10.7

16.9

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

16.7

227

1185

G02.0

ICD-10 Finland

Meningitis in viral diseases classified elsewhere

+∞

16.7

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

16.6

625

4378

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

16.6

200

994

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

16.6

383

2377

N05CF01

ATC

zopiclone; oral

1.4

16.6

1105

8631

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

16.5

346

2087

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

3.7

16.5

197

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

16.5

259

1426

E000004

ATC

2.9

16.5

102

361

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.2

16.4

267

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

16.4

310

1813

L03AA13

ATC

pegfilgrastim; parenteral

2.3

16.3

151

668

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.1

16.2

184

893

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.7

16.2

195

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

16.1

301

1752

SPAT1263

SPAT

Sampling

1.3

16.1

1582

13126

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.4

16.0

228

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

15.7

323

1937

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

4.3

15.5

134

R06AX22

ATC

ebastine; oral

1.5

15.5

663

4765

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

15.5

110

424

S01EC01

ATC

acetazolamide; systemic

2.9

15.3

314

F03

ICPC

Eye discharge

1.9

15.3

237

1296

G53.0

ICD-10 Finland

Postzoster neuralgia

6.7

15.2

S01GX02

ATC

levocabastine; ophthalmic

1.9

15.2

238

1308

H19.2

ICD-10 Finland

Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere

28.7

15.2

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

15.1

886

6758

137

Kela drug reimbursment

Uraemia requiring dialysis

5.6

15.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

15.1

417

2714

XQ848

NOMESCO Finland

Dermatological photography

2.8

15.0

365

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

15.0

1820

15509

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

14.9

346

M03BX02

ATC

tizanidine; oral

1.3

14.9

2391

21142

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.6

14.9

189

H16.1

ICD-10 Finland

Other superficial keratitis without conjunctivitis

6.5

14.9

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

14.9

941

7268

S87

ICPC

Dermatitis/atopic eczema

2.7

14.8

100

372

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

14.8

820

6183

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.0

14.8

WX002

NOMESCO Finland

Sedation and analgesia

1.4

14.8

658

4762

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

16.5

14.7

CG2S4

NOMESCO Finland

Photography of cornea

8.3

14.7

B01.9

ICD-10 Finland

Varicella without complication

18.4

14.7

J01FA09

ATC

clarithromycin; systemic

1.3

14.7

1173

9401

WZC30

NOMESCO Finland

Teaching

1.6

14.6

450

3005

TCG10

NOMESCO Finland

Removal of sutures from cornea

7.4

14.6

R74

ICPC

Upper respiratory infection acute

1.3

14.6

1094

8677

B00.7

ICD-10 Finland

Disseminated herpesviral disease

+∞

14.6

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

14.6

280

1646

ZXA00

NOMESCO Finland

Right side

1.4

14.5

899

6914

C07AB07

ATC

bisoprolol; oral

1.3

14.4

1497

12461

B00

ICD-10 Finland

Herpesviral [herpes simplex] infections

10.1

14.4

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.8

14.4

159

R03BA01

ATC

beclometasone; inhalant

1.5

14.4

506

3485

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

14.4

210

1126

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

12.6

14.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

14.3

832

6325

SPAT1153

SPAT

Removal of sutures

1.3

14.3

1076

8533

R01AD01

ATC

beclometasone; nasal

1.5

14.2

567

4010

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

14.2

167

824

R01AD12

ATC

fluticasone furoate; nasal

1.3

14.2

1130

9044

R02

ICPC

Shortness of breath/dyspnoea

1.6

14.2

394

2569

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

14.1

290

1741

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

14.1

290

1742

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

42.6

14.1

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

14.1

235

1322

A03

ICPC

Fever

1.5

14.0

582

4154

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

14.0

979

7672

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

14.0

243

1384

B05DA

ATC

Isotonic solutions

6.6

14.0

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.9

14.0

P01BA02

ATC

hydroxychloroquine; oral

1.7

13.9

296

1795

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.1

13.9

244

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.8

13.8

150

N05BA04

ATC

oxazepam; oral

1.4

13.8

888

6867

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

13.8

226

1261

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

13.7

319

1982

R52.9

ICD-10 Finland

Pain, unspecified

1.7

13.7

291

1762

A11CC03

ATC

alfacalcidol; systemic

2.9

13.7

294

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

13.7

641

4680

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

13.7

170

858

R53

ICD-10 Finland

Malaise and fatigue

1.4

13.7

710

5286

B01AB05

ATC

enoxaparin; parenteral

1.3

13.7

1010

7982

L51.9

ICD-10 Finland

Erythema multiforme, unspecified

9.1

13.7

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

13.7

333

2097

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

6.9

13.6

M79.1

ICD-10 Finland

Myalgia

1.5

13.6

457

3118

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

13.5

372

2415

H13.1*B02.3

ICD-10 Finland

Zoster conjunctivitis

+∞

13.5

B00.3

ICD-10 Finland

Herpesviral meningitis

+∞

13.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

13.5

177

912

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

13.5

421

2820

A01

ICPC

Pain general/multiple sites

1.7

13.5

265

1571

CG2T4

NOMESCO Finland

Topography assessment of cornea

4.7

13.5

A12AA04

ATC

calcium carbonate; oral

3.6

13.4

169

H16.8

ICD-10 Finland

Other keratitis

9.4

13.4

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

9.4

13.4

R60.0

ICD-10 Finland

Localized oedema

1.6

13.4

344

2195

H26.2

ICD-10 Finland

Complicated cataract

3.7

13.3

155

F73

ICPC

Eye infection/inflammation other

2.8

13.3

319

N03AF01

ATC

carbamazepine; oral, rectal

2.0

13.3

179

931

R03AC03

ATC

terbutaline; inhalant

1.5

13.3

518

3649

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

13.2

527

3726

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.7

13.2

337

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

13.2

573

4124

S29

ICPC

Skin symptom/complaint other

1.5

13.2

562

4028

C08CA01

ATC

amlodipine; oral

1.3

13.1

1063

8510

R4110

NOMESCO Finland

Physiotherapy

1.4

13.1

898

7011

H15.1

ICD-10 Finland

Episcleritis

3.1

12.9

234

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

12.9

258

1539

H02AB02

ATC

dexamethasone; systemic

1.6

12.8

341

2198

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

12.8

463

3205

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

12.7

1131

9171

A04AA02

ATC

granisetron; systemic, transdermal

1.8

12.7

208

1163

D06BX01

ATC

metronidazole; topical

1.6

12.6

380

2522

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

12.6

320

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

12.6

441

3031

R11

ICD-10 Finland

Nausea and vomiting

1.7

12.6

277

1697

B94.1

ICD-10 Finland

Sequelae of viral encephalitis

70.1

12.6

H26.3

ICD-10 Finland

Drug-induced cataract

6.4

12.6

N06AX11

ATC

mirtazapine; oral

1.3

12.6

1129

9166

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.4

12.6

100

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

12.5

118

529

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

12.5

2740

24920

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

5.5

12.5

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

17.3

12.5

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

12.5

229

N06AB10

ATC

escitalopram; oral

1.4

12.5

742

5653

B05DB

ATC

Hypertonic solutions

7.3

12.4

H22.0

ICD-10 Finland

Iridocyclitis in infectious and parasitic diseases classified elsewhere

130.4

12.4

R05

ICPC

Cough

1.4

12.4

791

6091

H26.4

ICD-10 Finland

After-cataract

1.7

12.4

253

1515

XA800

NOMESCO Finland

Neuropsychological investigation

2.1

12.4

144

708

K12.10

ICD-10 Finland

Stomatitis NOS

6.0

12.4

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

12.4

343

2235

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

12.3

812

6289

H18.1

ICD-10 Finland

Bullous keratopathy

11.6

12.3

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

12.3

231

1349

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

12.2

243

1442

120

Kela drug reimbursment

Hypogammaglobulinaemia

14.3

12.2

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

8.4

12.2

ZXA05

NOMESCO Finland

Left side

1.4

12.2

816

6335

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

12.1

469

3295

S70

ICPC

Herpes zoster

2.7

12.1

310

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.0

12.1

223

S01XA18

ATC

ciclosporin; ophthalmic

5.4

12.0

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

12.0

2053

18077

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.5

12.0

354

F02

ICPC

Red eye

2.0

12.0

148

745

R05

ICD-10 Finland

Cough

1.4

12.0

664

4993

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

12.0

194

1081

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

10.0

12.0

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

11.9

239

1426

S01EA03

ATC

apraclonidine; ophthalmic

4.4

11.8

B03XA01

ATC

erythropoietin; parenteral

4.6

11.8

A04AA01

ATC

ondansetron; systemic, rectal

1.7

11.7

221

1294

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

11.7

154

796

H53.2

ICD-10 Finland

Diplopia

2.4

11.7

423

K50.8

ICD-10 Finland

Other Crohn disease

3.0

11.6

218

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

11.6

141

707

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

11.6

460

3243

WW300

NOMESCO Finland

Transfer of autologic stem cells

6.0

11.6

D11

ICPC

Diarrhoea

1.5

11.6

392

2674

A87.8

ICD-10 Finland

Other viral meningitis

65.1

11.6

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.4

11.6

100

429

K02.1

ICD-10 Finland

Caries of dentine

1.2

11.5

2155

19138

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

11.5

205

1177

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

11.5

314

2037

A01AB09

ATC

miconazole; local oral

1.6

11.5

300

1924

D07AB01

ATC

clobetasone; topical

2.1

11.5

122

579

0544C

ICD-9 Finland

Herpes simplex, With ophthalmic complications[KERATITIS DISCIFORMIS, HERPETICA]

+∞

11.5

0544A

ICD-9 Finland

Herpes simplex, With ophthalmic complications[HERPES SIMPLEX PALPEBRAE OCULI]

+∞

11.5

0543B

ICD-9 Finland

Herpes simplex, Herpetic meningoencephalitis[ENCEPHALITIS HERPETICA]

+∞

11.5

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

11.4

504

3634

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

11.4

854

6741

SPAT1254

SPAT

Administration of medicine

1.5

11.4

473

3370

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.4

11.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

11.3

400

2753

S01EE01

ATC

latanoprost; ophthalmic

1.8

11.3

177

975

J01EA01

ATC

trimethoprim; systemic

1.3

11.3

911

7270

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

11.2

131

647

N06AA09

ATC

amitriptyline; systemic

1.6

11.2

336

2228

Z51.5

ICD-10 Finland

Palliative care

1.9

11.2

168

911

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.9

11.2

236

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

11.1

379

2590

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

11.1

978

7897

134

Kela drug reimbursment

General erythroderma

6.4

11.1

SPAT1255

SPAT

Intravenous administration of medicine

1.8

11.0

204

1185

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

11.0

165

894

N06AX16

ATC

venlafaxine; oral

1.4

11.0

496

3590

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

11.0

236

1435

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

11.0

424

2977

A06AD11

ATC

lactulose; oral

1.5

11.0

428

3008

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.4

10.9

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

10.9

407

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

10.9

235

1432

J45

ICD-10 Finland

Asthma

1.5

10.9

332

2211

M01AE02

ATC

naproxen; oral, rectal

1.2

10.9

2148

19146

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

10.9

277

1766

N77.1*A60.0

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection

5.7

10.8

N01

ICPC

Headache

1.5

10.8

370

2531

L08.0

ICD-10 Finland

Pyoderma

3.7

10.8

126

H01

ICPC

Ear pain/earache

1.5

10.8

372

2549

R21

ICPC

Throat symptom/complaint

1.3

10.8

716

5544

A41.8

ICD-10 Finland

Other specified sepsis

3.0

10.6

198

N30.0

ICD-10 Finland

Acute cystitis

1.4

10.6

473

3416

R03BB04

ATC

tiotropium bromide; inhalant

1.6

10.6

284

1834

N05CF02

ATC

zolpidem; oral

1.4

10.6

614

4648

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

6.3

10.6

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

10.6

742

5792

M01AB05

ATC

diclofenac; systemic, rectal

1.2

10.5

2497

22675

M05BA04

ATC

alendronic acid; oral

1.6

10.5

242

1503

H02.4

ICD-10 Finland

Ptosis of eyelid

2.4

10.5

374

R03AC13

ATC

formoterol; inhalant

1.8

10.5

163

897

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

4.8

10.5

A02BC03

ATC

lansoprazole; oral

1.3

10.5

980

7967

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

10.5

1428

12178

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

10.5

230

1410

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

10.5

223

1353

A02BA02

ATC

ranitidine; systemic

1.4

10.4

638

4870

05699

ICD-8 Finland

Rubella, Non definita

+∞

10.4

B02.0

ICD-10 Finland

Zoster encephalitis

+∞

10.4

B005H

ICD-10 Finland

+∞

10.4

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

4.2

10.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

10.4

144

761

N18.8

ICD-10 Finland

Other chronic renal failure

2.4

10.3

353

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

10.3

126

633

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

10.3

161

888

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.9

10.3

141

742

L57.0

ICD-10 Finland

Actinic keratosis

1.6

10.3

263

1679

A07EA06

ATC

budesonide; oral, local oral

2.1

10.2

119

587

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

10.2

303

UKC02

NOMESCO Finland

Cystoscopy

1.4

10.2

454

3274

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.1

10.2

107

505

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.3

10.2

N06AX21

ATC

duloxetine; oral

1.5

10.2

380

2647

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

10.1

231

1429

H00.03

ICD-10 Finland

Preseptal cellulite in the eyelid

6.2

10.1

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

4.2

10.1

D06BB06

ATC

penciclovir; topical

5.2

10.1

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

10.1

229

1416

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.9

10.1

205

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

10.0

227

1404

J01CF05

ATC

flucloxacillin; systemic

2.0

10.0

120

601

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

10.0

103

482

114

Kela drug reimbursment

Glaucoma

1.6

10.0

238

1489

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

10.0

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

10.0

133

695

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

10.0

117

579

H03AA01

ATC

levothyroxine sodium; systemic

1.3

10.0

811

6462

K12.00

ICD-10 Finland

Recurrent oral aphthae

3.0

10.0

193

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

9.9

804

6404

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.0

9.9

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

9.9

392

2766

395

Kela drug reimbursment

Dupilumab

16.7

9.9

R51.81

ICD-10 Finland

Facial pain NOS

2.3

9.8

373

S22.3

ICD-10 Finland

Fracture of rib

1.7

9.8

197

1178

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

12.2

9.8

L17

ICPC

Foot/toe symptom/complaint

1.3

9.8

829

6639

1XC02

NOMESCO Finland

4.2

9.8

WX290

NOMESCO Finland

Other blockade of nerve

1.2

9.8

1638

14273

SBB10

NOMESCO Finland

Teeth copy

1.7

9.8

215

1318

WX892

NOMESCO Finland

Monitored bed care

1.6

9.8

233

1460

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

9.8

233

1462

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.2

9.8

154

N06AB04

ATC

citalopram; systemic

1.3

9.8

740

5839

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

9.7

315

2129

H18.6

ICD-10 Finland

Keratoconus

4.5

9.7

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

4.5

9.7

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.9

9.7

192

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

9.7

111

547

N03AE01

ATC

clonazepam; systemic

1.7

9.7

195

1165

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.6

9.7

118

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

9.7

244

1552

CGF35

NOMESCO Finland

Repair of cornea using graft

55.1

9.6

L30.3

ICD-10 Finland

Infective dermatitis

2.0

9.6

115

576

X58

ICD-10 Finland

Exposure to other specified factors

1.4

9.6

454

3310

S01GX09

ATC

olopatadine; ophthalmic

2.2

9.6

458

XCK00

NOMESCO Finland

Perimetry

1.7

9.6

211

1292

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

9.6

180

1054

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

9.5

1414

12147

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

9.5

272

1783

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.7

9.5

176

1025

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

9.5

2138

19206

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

9.5

1293

11000

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.6

9.5

115

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

9.4

227

1429

XCH00

NOMESCO Finland

Eye pressure measurement

1.9

9.4

124

647

H62.1*B02.8

ICD-10 Finland

Otitis externa in zoster

+∞

9.4

G05.1*B02.0

ICD-10 Finland

Zoster encephalitis

+∞

9.4

H190, B005

ICD-10 Finland

+∞

9.4

J20

ICD-10 Finland

Acute bronchitis

1.5

9.4

315

2148

JN6AD

NOMESCO Finland

CT of torso and neck

3.1

9.3

154

N77.0*A60.0

ICD-10 Finland

Ulceration of vulva in herpesviral [herpes simplex] infection

6.9

9.3

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.8

9.2

165

955

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.7

9.2

182

1084

SPAT1301

SPAT

No procedures

1.3

9.2

1064

8874

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.3

9.2

134

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

2.6

9.2

249

D07AC14

ATC

methylprednisolone aceponate; topical

1.8

9.2

164

947

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

9.1

1071

8946

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

9.1

264

1739

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

9.1

500

3750

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

9.0

154

877

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.9

9.0

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

9.0

127

678

A05AA02

ATC

ursodeoxycholic acid; oral

2.5

9.0

282

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

10.0

9.0

Z49.2

ICD-10 Finland

Other dialysis

4.7

9.0

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

9.0

254

1662

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

3.6

9.0

105

K59.0

ICD-10 Finland

Constipation

1.7

9.0

168

986

49300

ICD-8 Finland

Asthma, bronchiale

2.3

8.9

361

R07.3

ICD-10 Finland

Other chest pain

1.5

8.9

286

1929

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

8.9

160

927

L27.2

ICD-10 Finland

Dermatitis due to ingested food

3.7

8.9

101

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

8.8

237

1534

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

8.8

285

1925

G47.3

ICD-10 Finland

Sleep apnoea

1.3

8.8

641

5020

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

8.8

121

640

L50.8

ICD-10 Finland

Other urticaria

2.5

8.8

272

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.7

8.8

206

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

8.6

8.8

K30

ICD-10 Finland

Functional dyspepsia

1.5

8.8

332

2322

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

8.8

890

7294

R05FB02

ATC

cough suppressants and expectorants

1.2

8.8

1278

10935

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

6.3

8.8

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

8.7

1775

15728

R55

ICD-10 Finland

Syncope and collapse

1.5

8.7

320

2220

C83.1

ICD-10 Finland

Mantle cell lymphoma

5.9

8.7

Z00.0

ICD-10 Finland

General medical examination

1.3

8.7

611

4756

R07.0

ICD-10 Finland

Pain in throat

1.6

8.7

207

1297

A10AE04

ATC

insulin glargine; parenteral

1.5

8.7

272

1826

L04AA05

ATC

[U] tacrolimus; systemic

14.0

8.7

L71.8

ICD-10 Finland

Other rosacea

2.7

8.7

215

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

8.7

205

1284

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.1

8.7

420

L88

ICPC

Rheumatoid/seropositive arthritis

1.9

8.6

124

667

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

8.6

1403

12145

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

7.6

8.6

G50.1

ICD-10 Finland

Atypical facial pain

2.5

8.6

269

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

8.6

978

8127

N05AH04

ATC

quetiapine; oral

1.3

8.6

549

4215

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.5

8.6

252

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

8.6

477

3579

S21

ICPC

Skin texture symptom/complaint

1.4

8.6

379

2734

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.4

8.5

350

2486

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

3.0

8.5

159

SPAT1260

SPAT

Consultation of another employee

1.3

8.5

589

4577

M54.2

ICD-10 Finland

Cervicalgia

1.6

8.5

229

1485

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.8

8.5

182

D07XC01

ATC

betamethasone, combinations; topical

1.4

8.5

374

2693

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.7

8.5

H10.2

ICD-10 Finland

Other acute conjunctivitis

2.9

8.5

169

S01FA02

ATC

scopolamine; ophthalmic

3.3

8.5

121

S01GX05

ATC

lodoxamide; ophthalmic

2.9

8.5

176

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.2

8.5

397

CD2S4

NOMESCO Finland

Photography of eye

4.5

8.5

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.1

8.4

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.8

8.4

183

R52.2

ICD-10 Finland

Other chronic pain

1.9

8.4

114

601

C02AC05

ATC

moxonidine; oral

1.9

8.4

122

660

L03.2

ICD-10 Finland

Cellulitis of face

3.8

8.4

R96

ICPC

Asthma

1.5

8.4

280

1909

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

8.4

985

8218

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.4

8.4

117

ZX112

NOMESCO Finland

Subcutaneous

2.2

8.4

358

H192, B005

ICD-10 Finland

+∞

8.3

05209

ICD-8 Finland

Chickenpox, Unspecified

+∞

8.3

37100

ICD-8 Finland

Corneal opacity, Cicatrix (nubecula, macula, leucoma) cornea

+∞

8.3

R06AX26

ATC

fexofenadine; oral

1.6

8.3

230

1500

W19

ICD-10 Finland

Unspecified fall

1.5

8.3

285

1952

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.2

8.3

360

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

8.3

142

810

M05BX04

ATC

denosumab; parenteral

1.8

8.3

136

765

N05BA01

ATC

diazepam; systemic, rectal

1.4

8.3

426

3158

CKD15

NOMESCO Finland

Injection of vitreous substitute

5.2

8.3

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.6

8.3

220

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.4

8.3

113

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

8.2

269

1822

S01EC04

ATC

brinzolamide; ophthalmic

2.0

8.2

104

535

M54.3

ICD-10 Finland

Sciatica

1.6

8.2

186

1154

K08.80

ICD-10 Finland

Toothache NOS

1.5

8.2

270

1835

SPAT1312

SPAT

General health counselling

1.2

8.2

1124

9541

L71.9

ICD-10 Finland

Rosacea, unspecified

2.2

8.1

345

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

5.1

8.1

J01FA01

ATC

erythromycin; systemic

1.3

8.1

502

3833

J02AC02

ATC

itraconazole; systemic

1.3

8.1

613

4824

S01FA01

ATC

atropine; ophthalmic

4.7

8.1

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.3

8.1

319

UDC00

NOMESCO Finland

Ear microscopy

1.6

8.1

224

1462

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

8.1

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

10.0

8.0

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

8.0

405

2993

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

8.0

1954

17576

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

8.0

436

C05AA08

ATC

fluocortolone; rectal, topical

1.4

8.0

463

3500

R51

ICD-10 Finland

Headache

1.7

8.0

175

1076

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.7

8.0

189

D09AB01

ATC

zinc bandage without supplements; topical

2.3

7.9

295

WW409

NOMESCO Finland

Other aferesis

7.2

7.9

R02AD02

ATC

lidocaine; local oral

2.2

7.9

369

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

7.9

168

1024

C07AB02

ATC

metoprolol; systemic

1.3

7.9

590

4634

Z01.2

ICD-10 Finland

Dental examination

1.2

7.9

1461

12791

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.0

7.9

480

A92

ICPC

Allergy/allergic reaction NOS

2.0

7.9

468

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

7.8

244

1640

B34.9

ICD-10 Finland

Viral infection, unspecified

2.0

7.8

497

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

7.8

132

751

F70

ICPC

Conjunctivitis infectious

2.1

7.8

377

J01AA04

ATC

lymecycline; systemic

1.4

7.8

455

3445

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.8

7.8

128

723

H01.9

ICD-10 Finland

Inflammation of eyelid, unspecified

2.9

7.8

147

L04AA13

ATC

leflunomide; oral

2.0

7.8

439

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.7

490

3758

N18.0

ICD-10 Finland

End-stage renal disease

3.0

7.7

136

K12.18

ICD-10 Finland

Other forms of stomatitis

3.6

7.7

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

7.7

634

5048

G50.8

ICD-10 Finland

Other disorders of trigeminal nerve

7.4

7.7

ED1AA

NOMESCO Finland

Mandipular X-ray examination

3.9

7.6

SPAT1216

SPAT

Assessment of functional ability

1.4

7.6

425

3192

-1

NOMESCO Finland

1.2

7.6

1190

10233

L01

ICPC

Neck symptom/complaint

1.4

7.6

435

3284

WX402

NOMESCO Finland

General anaesthesia

1.3

7.5

532

4146

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

7.5

221

1462

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

7.5

272

YNB10

NOMESCO Finland

Collection of stem cells for transplant

8.8

7.5

V03AE01

ATC

polystyrene sulfonate; oral

3.0

7.5

139

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

7.5

164

1007

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

7.5

920

7699

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.6

7.5

192

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

7.5

164

1011

J46

ICD-10 Finland

Status asthmaticus

2.0

7.5

470

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.1

7.5

407

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

7.4

131

758

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

7.4

728

5931

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

7.4

515

R03BA08

ATC

ciclesonide; inhalant

1.5

7.4

269

1866

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.4

2645

24575

ZX121

NOMESCO Finland

Central venous catheter

5.3

7.4

L01

ICD-10 Finland

Impetigo

2.7

7.4

181

G01AF05

ATC

econazole; vaginal

1.5

7.4

269

1871

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

7.4

169

1052

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

5.6

7.4

H00.1

ICD-10 Finland

Chalazion

1.8

7.3

111

612

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

2.9

7.3

145

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.1

7.3

125

0548X

ICD-9 Finland

Herpes simplex, With unspecified complication

+∞

7.3

05710

ICD-8 Finland

Other viral exanthem, Exanthema subitum (sixth disease)

+∞

7.3

D07CB01

ATC

triamcinolone and antibiotics; topical

2.1

7.3

348

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

7.3

173

1087

L51.8

ICD-10 Finland

Other erythema multiforme

9.4

7.3

M03BX01

ATC

baclofen; systemic

2.3

7.3

264

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.9

7.3

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

7.3

397

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

7.2

309

2215

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

6.2

7.2

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

6.2

7.2

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.6

7.2

166

1036

C90.0

ICD-10 Finland

Multiple myeloma

3.4

7.2

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.6

7.2

194

H25.8

ICD-10 Finland

Other senile cataract

1.5

7.2

255

1762

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.9

7.2

507

WZA90

NOMESCO Finland

Other doctors statement

1.3

7.2

756

6216

J30.3

ICD-10 Finland

Other allergic rhinitis

1.8

7.1

121

692

L28

ICPC

Limited function/disability (L)

1.3

7.1

431

3280

C10AA05

ATC

atorvastatin; oral

1.2

7.1

1066

9108

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

30.0

7.1

A10AE05

ATC

insulin detemir; parenteral

1.6

7.1

162

1007

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.4

7.1

248

H16.4

ICD-10 Finland

Corneal neovascularization

20.0

7.1

D11AH05

ATC

dupilumab; topical

20.0

7.1

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

20.0

7.1

H17.0

ICD-10 Finland

Adherent leukoma

20.0

7.1

B02.20

ICD-10 Finland

Herpes zoster trigeminal neuralgia

20.0

7.1

N05CD08

ATC

midazolam; nasal, systemic

2.3

7.1

280

G04CA02

ATC

tamsulosin; oral

1.3

7.1

511

3989

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

7.1

390

2920

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

7.9

7.1

S06.0

ICD-10 Finland

Concussion

1.4

7.1

318

2298

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.2

7.1

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

7.1

241

1652

D01

ICPC

Abdominal pain/cramps general

1.4

7.1

338

2472

R01AD05

ATC

budesonide; nasal

1.5

7.1

255

1767

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.5

7.1

272

1911

TK820

NOMESCO Finland

Peritoneal dialysis

5.6

7.0

B01AB10

ATC

tinzaparin; parenteral

1.5

7.0

202

1332

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.8

7.0

151

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

3.3

7.0

101

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

7.0

438

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.0

7.0

452

H92.0

ICD-10 Finland

Otalgia

1.6

7.0

161

1006

J01AA07

ATC

tetracycline; systemic

1.3

7.0

524

4116

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.2

7.0

107

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

7.0

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

7.0

248

1713

S01AA02

ATC

chlortetracycline; ophthalmic

3.5

7.0

R78

ICPC

Acute bronchitis/bronchiolitis

2.2

6.9

310

D07XB05

ATC

dexamethasone, combinations; topical

1.9

6.9

457

A07AA09

ATC

vancomycin; oral

2.8

6.9

153

A07EC02

ATC

mesalazine; oral, rectal

1.6

6.9

171

1087

M01CB01

ATC

sodium aurothiomalate; parenteral

2.5

6.9

212

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

13.8

6.9

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.9

584

4669

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.8

6.9

118

676

T74.1

ICD-10 Finland

Physical abuse

2.2

6.9

304

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.4

6.8

347

2567

J47

ICD-10 Finland

Bronchiectasis

2.4

6.8

222

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

6.8

137

822

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

6.8

624

5034

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.4

6.8

N30

ICD-10 Finland

Cystitis

1.5

6.8

245

1699

Z00.8

ICD-10 Finland

Other general examinations

1.5

6.8

214

1441

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.1

6.8

328

R4120

NOMESCO Finland

Occupational therapy

1.5

6.8

196

1295

M31.7

ICD-10 Finland

Microscopic polyangiitis

10.9

6.8

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

9.3

6.8

69519

ICD-8 Finland

Erythematous condition, Erythema multiforme NUD

40.1

6.8

S83.2

ICD-10 Finland

Tear of meniscus, current

1.5

6.7

209

1403

36399

ICD-8 Finland

Keratitis, Without mention of ulcer

16.7

6.7

WXQ24

NOMESCO Finland

UVB/UVA light therapy

16.7

6.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

6.7

153

952

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.3

6.7

268

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

6.7

1364

12008

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

6.7

394

2985

A06AC51

ATC

ispaghula, combinations; systemic

1.6

6.7

149

921

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

6.7

527

4173

ZX131

NOMESCO Finland

Intrathecal

22.5

6.7

J01MA01

ATC

ofloxacin; systemic

1.5

6.7

243

1691

SPAT1262

SPAT

Handing over of treatment supplies

1.3

6.6

524

4148

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.7

6.6

132

793

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

2.9

6.6

132

Z94.2

ICD-10 Finland

Lung transplant status

7.8

6.6

C10AC01

ATC

colestyramine; oral

2.0

6.6

429

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.6

6.6

142

873

D69.5

ICD-10 Finland

Secondary thrombocytopenia

5.5

6.6

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.4

6.6

224

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.0

6.6

379

SPAT1310

SPAT

Counselling related to known health issue

1.2

6.6

1083

9338

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

6.6

207

1395

CFD10

NOMESCO Finland

Repair of conjunctiva

12.2

6.6

M02AA07

ATC

piroxicam; topical

1.2

6.6

1197

10421

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.1

6.6

354

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

6.6

354

S01BC05

ATC

ketorolac; ophthalmic

1.8

6.6

108

612

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.5

602

4859

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

8.7

6.5

B01AF02

ATC

apixaban; oral

1.5

6.5

240

1672

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

6.5

167

1075

ZXC50

NOMESCO Finland

Cryotherapy

2.0

6.5

369

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

6.5

187

1237

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

6.5

364

2735

L73.8

ICD-10 Finland

Other specified follicular disorders

3.0

6.5

119

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.5

6.5

182

S76

ICPC

Skin infection other

1.6

6.5

141

870

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

6.5

496

N05CD07

ATC

temazepam; oral

1.4

6.5

344

2564

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.8

6.5

109

621

U02

ICPC

Urinary frequency/urgency

1.3

6.5

406

3106

A28

ICPC

Limited function/disability NOS

1.3

6.5

379

2872

H40.0

ICD-10 Finland

Glaucoma suspect

1.5

6.5

210

1426

D06BB04

ATC

podophyllotoxin; topical

1.6

6.4

171

1110

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.8

6.4

514

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

2.9

6.4

120

B02.7

ICD-10 Finland

Disseminated zoster

69.9

6.4

M79.7

ICD-10 Finland

Fibromyalgia

1.7

6.4

116

678

V03AE02

ATC

sevelamer; oral

4.2

6.4

L51.1

ICD-10 Finland

Bullous erythema multiforme

14.3

6.4

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

14.3

6.4

L30.0

ICD-10 Finland

Nummular dermatitis

1.8

6.4

550

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.9

6.4

130

R04.0

ICD-10 Finland

Epistaxis

1.5

6.4

184

1218

J01DA06

ATC

[U] cefuroxime; systemic

1.3

6.4

475

3730

-59

ICPC

Other therap proced/minor surg NEC

1.9

6.4

448

N03AG01

ATC

valproic acid; systemic, rectal

1.5

6.4

194

1298

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

6.4

136

834

K11.2

ICD-10 Finland

Sialoadenitis

1.8

6.3

538

S20.2

ICD-10 Finland

Contusion of thorax

1.6

6.3

136

836

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.6

6.3

154

979

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.8

6.3

509

SPAT1325

SPAT

Vaccination

1.2

6.3

1080

9338

R06.2

ICD-10 Finland

Wheezing

1.7

6.3

132

803

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.4

6.3

335

2499

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

6.3

324

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

6.3

473

3719

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.8

6.3

106

609

D01AC02

ATC

miconazole; topical

1.5

6.3

225

1559

3604

FHL

Penetration of the cornea

18.0

6.3

3718X

ICD-9 Finland

Corneal opacity and other disorders of cornea, Other corneal disorders

18.0

6.3

N99

ICPC

Neurological disease other

2.6

6.3

156

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

6.2

170

05300

ICD-8 Finland

Herpes zoster, Opthalmicus

+∞

6.2

G03.1

ICD-10 Finland

Chronic meningitis

+∞

6.2

05404

ICD-8 Finland

Herpes simplex, Meningoencephalitis herpetica

+∞

6.2

G63.0*B02.29

ICD-10 Finland

Postherpetic polyneuropathy

+∞

6.2

G05.1*B01.1

ICD-10 Finland

Varicella encephalitis

+∞

6.2

0543A

ICD-9 Finland

Herpes simplex, Herpetic meningoencephalitis[MENINGITIS HERPETICA]

+∞

6.2

D84.1

ICD-10 Finland

Defects in the complement system

+∞

6.2

D06

ICPC

Abdominal pain localized other

1.4

6.2

249

1764

J01CA08

ATC

pivmecillinam; oral

1.2

6.2

1452

12915

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

6.2

246

1739

N06AA10

ATC

nortriptyline; systemic

2.0

6.2

352

A05

ICPC

Feeling ill

1.5

6.2

185

1230

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.1

6.2

304

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

6.2

959

8207

3700A

ICD-9 Finland

Keratitis, Corneal ulcer

26.7

6.2

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

6.2

162

1045

A02BA04

ATC

nizatidine; systemic

1.5

6.2

226

1571

WX140

NOMESCO Finland

Parabulbar anesthesy

1.7

6.2

114

668

S01

ICPC

Pain/tenderness of skin

1.7

6.2

126

763

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

6.2

177

1168

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

6.2

101

571

D06BB10

ATC

imiquimod; topical

1.6

6.2

141

881

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.5

6.2

183

S01AA12

ATC

tobramycin; ophthalmic

5.0

6.2

H11.4

ICD-10 Finland

Other conjunctival vascular disorders and cysts

3.9

6.2

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

3.8

6.2

R04.2

ICD-10 Finland

Haemoptysis

1.9

6.1

450

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.8

6.1

103

591

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.2

6.1

242

S01ED02

ATC

betaxolol; ophthalmic

3.1

6.1

C08CA13

ATC

lercanidipine; oral

1.4

6.1

345

2596

L12

ICPC

Hand/finger symptom/complaint

1.3

6.1

448

3511

B23.8

ICD-10 Finland

HIV disease resulting in other specified conditions

12.5

6.1

CKD20

NOMESCO Finland

Removal of vitreous body substitute

4.0

6.1

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

6.1

241

1706

M01AC06

ATC

meloxicam; systemic, rectal

1.2

6.1

1227

10776

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

6.0

778

6535

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

6.0

3610

34761

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

6.0

345

2602

-44

ICPC

Preventive immunization/medic

1.4

6.0

235

1660

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

10.0

6.0

L50.0

ICD-10 Finland

Allergic urticaria

1.9

6.0

461

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

6.0

568

4602

TEA00

NOMESCO Finland

Biopsy of lip

3.0

6.0

103

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

488

349

15.43

307.65

1.3

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

201

123

17.00

240.32

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

168

20.44

219.48

1.4

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

131

18.41

163.59

1.3

1.1

—

(3011412) CD3 cells [#/volume] in Blood

214

363

6.12

120.86

2.6

1.3

1.2

e9/l

0.38

144

221

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

175

273

6.61

107.28

2.6

2.2

—

(3001604) Monocytes [#/volume] in Blood

2760

19726

1.92

104.52

8.8

5.7

0.6

e9/l

1.11

2489

17091

(3006315) Basophils [#/volume] in Blood

2765

19800

1.92

103.80

8.8

5.8

0.0

e9/l

0.03

2492

17137

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

174

285

6.29

101.69

2.5

2.2

12.6

13.1

0.15

135

(3019198) Lymphocytes [#/volume] in Blood

2813

20372

1.90

100.72

8.8

5.8

1.9

e9/l

0.05

2561

18013

(1175426) CD3 cells/100 lymphocytes in Blood

175

292

6.18

100.39

2.6

2.2

75.5

73.1

1.23

168

282

(3013115) Eosinophils [#/volume] in Blood

2824

20502

1.90

100.07

9.2

6.0

0.2

e9/l

0.54

2557

18048

(42870588) Differential panel, method unspecified - Blood

2020

13169

1.91

99.94

8.7

5.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

276

690

4.18

98.99

8.2

5.2

675.7

550.0

iu/ml

0.15

(3005719) IgG [Mass/volume] in Serum or Plasma

676

2925

2.52

96.23

4.1

2.7

9.7

10.5

g/l

4.60

634

2679

(3022096) Basophils/100 leukocytes in Blood

2533

17944

1.86

94.96

9.1

5.9

0.7

0.33

2407

16741

(21494815) CD4 cells/100 lymphocytes in Specimen

176

313

5.80

94.54

2.6

2.4

39.2

44.8

0.48

(3007853) Bacteria identified in Skin by Aerobe culture

913

4550

2.24

94.04

2.0

1.7

—

(3019069) Monocytes/100 leukocytes in Blood

2600

18622

1.85

93.55

9.5

6.2

8.6

8.4

1.02

2480

17456

(3006504) Eosinophils/100 leukocytes in Blood

2586

18517

1.85

92.86

9.2

5.9

2.8

0.09

2457

17246

(3013650) Neutrophils [#/volume] in Blood by Automated count

3030

22893

1.86

90.37

14.0

8.8

4.1

4.0

e9/l

0.07

2739

20019

(3002030) Lymphocytes/100 leukocytes in Blood

2642

19229

1.82

88.07

9.2

5.9

27.9

28.5

2.02

2515

17944

(3018010) Neutrophils/100 leukocytes in Blood

2604

18959

1.80

85.81

8.8

5.8

57.1

56.9

0.30

2490

17748

(3023368) Bacteria identified in Blood by Culture

1547

9625

1.89

85.15

6.2

4.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

537

2293

2.51

77.80

2.3

1.9

1.1

1.4

g/l

4.10

498

2102

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

144

257

5.74

77.02

2.5

2.8

530.0

521.3

e6/l

0.06

114

219

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

209

526

4.11

74.12

4.3

2.7

34138.5

1423.6

u/ml

0.47

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

137

249

5.63

71.86

2.6

2.8

0.2

e9/l

0.44

115

218

(3028679) Herpes simplex virus Ab [Presence] in Serum

126

216

5.96

70.27

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3619

29981

1.81

68.13

11.4

7.2

78.2

77.2

u/l

0.50

3437

28255

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2620

19917

1.68

66.91

8.9

5.9

10.8

11.2

umol/l

0.79

2487

18852

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

134

261

5.25

65.16

2.8

2.7

682.7

700.3

e6/l

0.08

110

(3024561) Albumin [Mass/volume] in Serum or Plasma

2214

16208

1.67

64.45

6.8

4.6

35.1

35.8

g/l

6.24

2059

15090

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1002

5850

1.90

64.36

2.3

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

132

264

5.11

62.29

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

188

5.91

60.41

1.2

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

739

3984

2.01

59.62

6.4

4.1

244.7

245.4

u/l

0.04

698

3761

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

150

355

4.33

57.67

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2438

18727

1.60

55.41

10.1

6.3

1.2

mmol/l

0.86

2070

15800

(3013826) Glucose [Moles/volume] in Serum or Plasma

2818

22417

1.61

55.26

6.6

4.5

6.6

mmol/l

0.61

2656

20796

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

247

850

3.01

53.97

2.2

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

116

7.08

53.74

2.5

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1243

8121

1.71

53.34

1.8

1.4

2.2

2.3

g/l

0.83

825

5042

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

201

5.32

52.06

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

241

836

2.98

51.91

2.2

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

527

2633

2.12

51.85

2.3

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

710

3949

1.93

51.79

2.1

1.7

—

(3021589) Normoblasts [#/volume] in Blood

2292

17528

1.58

51.76

14.3

9.0

0.0

e9/l

0.47

1946

14298

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

167

464

3.69

51.47

2.2

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

148

6.11

51.20

2.4

2.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

145

6.16

51.09

2.6

2.4

11.4

10.1

0.40

138

(3013707) Erythrocyte sedimentation rate by Westergren method

3486

29486

1.64

50.69

5.6

3.9

12.8

11.5

mm/h

6.10

3268

27406

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

263

971

2.81

50.52

1.5

1.4

568.1

504.9

mg/l

1.18

254

916

(3017181) Myelocytes/100 leukocytes in Blood

600

3174

2.02

50.52

5.7

4.0

1.0

0.8

0.49

220

830

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

710

3985

1.92

50.30

2.2

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

193

606

3.28

49.23

2.3

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1330

9055

1.65

47.89

6.8

4.2

—

(3042936) Bacteria identified in Isolate by Culture

877

5337

1.78

47.71

2.4

2.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2197

16913

1.55

46.35

9.0

5.7

1.2

mmol/l

0.83

2047

15326

(3044290) Cell count panel - Cerebral spinal fluid

224

797

2.90

46.06

1.6

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

234

853

2.83

46.01

1.4

3.5

3.7

mmol/l

1.83

224

797

(3018418) pH of Serum or Plasma

1553

11068

1.59

45.97

6.4

3.8

7.4

0.46

356

2105

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

234

854

2.83

45.91

1.6

1.5

47.4

26.7

e6/l

1.09

198

661

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

234

855

2.82

45.81

1.7

1.6

321.5

1548.8

e6/l

2.29

204

697

(3003458) Phosphate [Moles/volume] in Serum or Plasma

789

4724

1.80

45.11

9.3

5.6

1.1

1.0

mmol/l

0.35

743

4397

(3000060) B lymphocytes [#/volume] in Blood

110

6.63

45.00

2.6

2.4

238.4

216.5

e6/l

0.17

(3005322) IgE [Units/volume] in Serum or Plasma

511

2660

2.03

44.75

1.7

1.3

1079.5

197.3

u/ml

3.12

469

2463

(3028433) Virus identified in Specimen by Culture

118

6.35

44.39

1.2

—

(3032080) INR in Blood by Coagulation assay

1930

14551

1.54

44.08

10.1

8.4

1.2

inr

2.02

643

4309

(3031040) Bacteria [#/volume] in Urine by Automated count

3127

26153

1.55

44.01

5.6

4.3

2355.5

1487.9

e6/l

0.30

331

(3021440) Promyelocytes/100 leukocytes in Blood

560

3030

1.96

43.89

5.8

4.1

0.1

0.2

0.07

203

766

(3000850) Epithelial cells [#/volume] in Urine

1177

7917

1.64

43.83

3.6

2.5

6.1

6.3

e6/l

0.20

1064

6923

(3037467) Urinalysis macro (dipstick) panel - Urine

3246

27390

1.56

43.75

5.7

4.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

138

379

3.72

43.27

2.2

1.6

—

(3018095) Leukocytes [#/volume] in Urine

1815

13609

1.53

41.92

5.0

3.5

63.9

101.0

e6/l

2.07

1355

9440

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1547

11207

1.56

41.75

2.4

2.1

206.6

212.6

u/l

0.06

1456

10535

(3012095) Magnesium [Moles/volume] in Serum or Plasma

932

5976

1.69

41.46

5.4

3.3

0.8

mmol/l

1.99

880

5564

(3002179) Metamyelocytes/100 leukocytes in Blood

535

2905

1.95

41.38

5.5

3.9

0.5

0.6

0.36

160

610

(3010375) cycloSPORINE [Mass/volume] in Blood

144

5.56

41.35

36.0

21.3

119.2

114.4

ug/l

0.24

113

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1638

12041

1.54

41.28

3.1

2.5

56.2

57.6

u/l

0.40

1516

11129

(3030467) Casts [#/volume] in Urine by Automated count

1459

10466

1.56

40.97

4.3

3.0

0.4

e6/l

0.17

1167

7847

(3000494) Fungus identified in Specimen by Culture

751

4558

1.77

40.65

1.7

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

524

2844

1.94

40.55

3.7

2.6

71.3

70.4

e9/l

0.22

402

2128

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

178

601

3.04

40.18

1.9

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

663

3903

1.81

39.73

4.2

2.6

1.9

1.8

1.14

606

3437

(3018677) aPTT in Platelet poor plasma by Coagulation assay

874

5571

1.69

39.56

2.6

2.2

29.7

0.05

856

5397

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1265

8846

1.58

39.43

2.1

1.8

1.1

mg/l

0.15

958

6685

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

201

4.65

39.16

3.6

2.5

41.4

41.7

0.04

(3021601) Nitrite [Presence] in Urine by Test strip

2429

19528

1.49

39.15

6.0

4.7

0.0

estimate

0.80

559

3666

(3025159) Blasts/100 leukocytes in Blood

523

2873

1.92

38.97

5.7

4.1

0.0

0.3

0.91

167

653

(3035350) Ketones [Presence] in Urine by Test strip

2418

19459

1.48

38.54

4.5

3.5

0.0

estimate

1.08

553

3594

(46235355) HIV 1 and 2 tests - Meaningful Use set

1205

8373

1.58

38.44

2.1

1.9

—

(3026782) Osmolality of Urine

1079

7306

1.61

38.37

3.9

2.7

526.2

542.5

mosm/kgh2o

1.72

975

6211

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

300

1344

2.31

38.34

2.3

1.9

1.2

1.7

ug/l

0.50

274

1194

(36304419) Bacteria [Presence] in Urine

1423

10283

1.54

38.10

4.2

2.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

906

5884

1.66

38.03

3.1

2.4

12.8

13.4

umol/l

1.76

855

5449

(3002582) Erythrocytes [#/volume] in Urine

1547

11398

1.52

37.80

4.5

3.1

49.3

92.7

e6/l

1.47

1262

8676

(3009261) Glucose [Presence] in Urine by Test strip

2441

19727

1.48

37.79

4.5

3.5

0.0

estimate

1.82

541

3590

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1817

13848

1.50

37.72

4.0

3.4

37.7

87.1

ng/l

0.74

1202

8719

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

224

4.35

37.64

1.9

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4378

40250

1.87

37.53

22.2

12.9

21.3

22.5

mg/l

1.68

3642

31576

(3026008) Bacteria identified in Urine by Culture

1561

11599

1.51

36.31

3.7

3.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2280

18304

1.46

35.76

3.5

2.9

145.4

108.8

ug/l

5.29

2137

17082

(40758558) Short blood count panel - Blood

1375

10002

1.52

35.14

10.1

6.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

6.37

34.99

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1692

12857

1.48

34.94

4.0

3.2

2.3

2.4

mmol/l

1.79

1484

11343

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

193

4.46

34.52

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1346

9777

1.52

34.52

3.9

2.4

4156.2

4385.7

umol/l

0.07

1183

8560

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2077

16484

1.45

34.00

2.7

2.2

76.8

76.5

nmol/l

0.27

1925

14984

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

266

1199

2.29

33.47

2.0

1.6

0.2

g/l

0.45

250

1128

(3004789) Transferrin [Mass/volume] in Serum or Plasma

825

5390

1.64

33.39

3.1

2.4

2.3

2.4

g/l

0.99

777

4986

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

774

4988

1.66

33.04

3.2

2.5

22.2

23.1

1.09

681

4275

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

272

1245

2.25

33.00

2.0

1.6

1.2

g/l

0.24

254

1173

(3020630) Protein [Mass/volume] in Serum or Plasma

495

2816

1.84

32.85

3.1

2.5

65.0

66.7

g/l

4.30

457

2583

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

127

396

3.27

32.81

1.9

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

534

3121

1.80

32.42

11.5

7.2

9.6

9.3

mmol/l

0.52

512

2981

(4062490)

128

409

3.19

31.77

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

127

404

3.20

31.76

1.7

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

759

4922

1.64

31.49

1.8

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1330

9791

1.49

31.42

2.6

2.2

3.0

2.9

mg/l

0.97

1173

8382

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

133

447

3.03

30.31

1.9

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

125

406

3.13

30.20

1.4

0.4

g/l

0.49

289

(3028192) IgG subclass 2 [Mass/volume] in Serum

125

406

3.13

30.20

1.4

2.9

g/l

0.02

290

(3027135) IgG subclass 1 [Mass/volume] in Serum

125

407

3.13

30.08

1.4

6.5

6.8

g/l

0.24

289

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

196

810

2.48

29.98

1.6

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

202

847

2.44

29.94

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

461

2.98

29.92

1.9

1.4

—

(40768443) Skin Pathology biopsy report

322

1635

2.04

29.89

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

280

1350

2.14

29.83

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

194

800

2.48

29.81

1.3

1.2

271.6

259.4

u/ml

0.18

134

491

(3024980) IgG subclass 4 [Mass/volume] in Serum

168

647

2.65

29.73

1.6

1.7

0.8

g/l

0.08

127

497

(3004588) Protein electrophoresis panel - Serum or Plasma

412

2283

1.88

29.62

3.0

2.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

263

3.66

29.52

2.2

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

189

774

2.50

29.48

4.8

3.7

55.3

57.4

1.13

189

774

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

242

1108

2.25

29.32

2.7

2.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1298

9628

1.47

29.12

3.3

3.0

1601.3

1328.6

ng/l

1.05

1123

8167

(3037522) Nuclear Ab [Titer] in Serum

834

5636

1.58

28.95

1.5

1.3

662.9

538.0

titre

0.81

171

1166

(3042111) Morphology [Interpretation] in Bone marrow Narrative

150

553

2.77

28.90

2.6

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

306

1547

2.04

28.74

1.7

1.5

16.1

16.4

u/ml

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

536

3248

1.73

28.55

5.9

3.9

5.8

kpa

0.05

526

3144

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

156

595

2.68

28.15

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1904

15251

1.41

27.81

2.1

1.9

98.0

96.6

pmol/l

0.63

1046

7868

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1263

9403

1.46

27.53

1.3

1.8

1.7

u/ml

0.08

340

2577

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

191

813

2.40

27.40

1.6

1.4

—

22.1

—

(3002032) Base excess in Venous blood by calculation

530

3240

1.71

27.30

6.0

3.9

2.0

1.9

mmol/l

0.25

440

2600

(3048689) Calprotectin [Mass/mass] in Stool

765

5131

1.58

27.29

2.7

2.3

136.4

122.8

ug/g

0.49

601

4073

(3029937) Albumin [Presence] in Urine by Test strip

1373

10412

1.44

27.06

5.1

3.9

0.0

estimate

1.49

544

3576

(3045142) Bone marrow Pathology biopsy report

115

380

3.08

27.02

1.7

1.4

—

(3025941) Bacteria identified in Stool by Culture

412

2351

1.82

26.91

1.4

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

141

524

2.74

26.77

1.9

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1150

8461

1.47

26.48

1.6

1.5

20.4

20.6

nmol/l

0.19

1036

7294

(3036481) Cortisol [Moles/volume] in Serum or Plasma

592

3762

1.65

26.29

2.5

2.1

351.3

374.8

nmol/l

2.14

553

3454

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3540

31674

1.43

26.07

4.5

4.1

14.6

14.7

pmol/l

0.82

3284

29064

(3037692) Legionella sp identified in Specimen by Organism specific culture

110

5.05

26.05

1.5

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

114

4.96

26.00

1.5

2.1

888.6

23999.3

u/ml

—

(3000991) Gas panel - Venous blood

483

2929

1.72

25.55

9.4

8.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

121

425

2.89

25.54

1.1

—

3.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

972

6966

1.49

25.39

1.8

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

254

1257

2.08

25.26

1.9

1.7

340.4

366.5

titre

0.04

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

174

738

2.41

25.18

1.7

1.4

103.2

112.6

u/ml

0.52

151

(3033658) Prothrombin time (PT) actual/Normal

1286

9763

1.43

24.79

5.3

3.8

91.7

92.0

0.13

1242

9502

(3023103) Potassium [Moles/volume] in Serum or Plasma

4354

40784

1.64

24.31

23.2

14.5

3.9

4.0

mmol/l

0.34

4262

39651

(3021879) Hepatitis B virus core Ab [Presence] in Serum

512

3199

1.67

24.18

1.6

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

178

778

2.34

24.08

1.9

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

220

1050

2.15

24.05

1.9

1.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.09

23.97

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1647

13127

1.38

23.72

4.3

3.1

33.2

34.5

u/l

0.25

1559

12492

(3022145) Colonoscopy Study observation

636

4218

1.58

23.57

1.4

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

149

4.20

23.50

37.6

33.3

7.1

7.5

ug/l

0.74

137

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

7.66

22.92

1.9

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

138

549

2.56

22.92

4.4

3.3

1.0

1.5

1.42

115

425

(3023410) Appearance of Cerebral spinal fluid

109

384

2.88

22.92

1.8

1.9

—

(40768797) Stomach Pathology biopsy report

771

5371

1.52

22.85

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

4.58

22.84

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

105

364

2.93

22.73

2.1

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4333

40653

1.60

22.67

22.9

14.4

139.5

139.7

mmol/l

6.22

4247

39603

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1851

15114

1.36

22.64

4.8

3.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

231

1150

2.06

22.61

3.4

2.7

3.6

g/l

0.12

221

1087

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1101

8245

1.43

22.53

1.8

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

492

3108

1.65

22.20

7.5

6.8

1.3

mmol/l

0.01

477

2998

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

232

3.40

21.83

1.6

1.5

20.8

19.2

u/ml

0.13

(3008536) Aspergillus sp Ab [Presence] in Serum

5.67

21.61

2.6

2.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

137

559

2.49

21.60

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

165

732

2.30

21.59

1.7

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

285

1553

1.89

21.50

1.7

1.8

1.5

g/l

0.12

247

1336

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

878

6367

1.46

21.18

3.4

2.6

1.1

1.2

e6/l

0.60

521

3588

(44790049)

110

410

2.72

20.84

2.1

1.4

—

(44790047)

110

410

2.72

20.84

2.1

1.4

—

(44790048)

110

410

2.72

20.84

2.1

1.4

—

(44806118)

110

410

2.72

20.84

2.1

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1189

9143

1.40

20.65

4.3

3.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

911

6690

1.45

20.49

1.8

1.7

1218.2

1167.4

nmol/l

0.76

699

5095

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4009

37183

1.44

20.32

5.4

4.8

2.3

2.0

mu/l

0.29

3751

34401

(3014576) Chloride [Moles/volume] in Serum or Plasma

646

4436

1.53

20.31

8.2

6.8

104.2

104.4

mmol/l

0.52

636

4340

(3024354) Oxygen [Partial pressure] in Venous blood

432

2705

1.66

20.12

4.9

3.3

4.6

kpa

0.28

425

2610

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

206

1029

2.05

20.00

1.5

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

182

3.61

19.97

2.2

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

182

3.61

19.97

2.2

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

643

4429

1.52

19.90

4.5

2.6

9.2

7.7

umol/l

0.70

570

3811

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

257

3.15

19.80

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

113

440

2.61

19.66

3.1

2.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

208

3.40

19.65

2.1

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

113

4.37

19.62

2.6

3.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3120

27858

1.33

19.59

3.6

3.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.75

19.54

1.9

1.5

1.8

1.5

mg/l

0.11

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

199

998

2.04

19.12

6.2

3.9

1.7

1.4

mg/l

2.53

189

924

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

939

7012

1.42

19.12

4.2

3.5

320.5

381.0

ng/l

0.22

679

5104

(40767503) Oxygen content in Capillary blood by calculation

161

745

2.20

19.07

3.1

2.4

15.9

16.2

0.28

368

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

435

2769

1.63

18.95

4.6

3.7

89.2

84.7

ng/l

0.46

369

2399

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

289

1651

1.80

18.73

2.1

1.9

40.7

39.3

u/l

0.54

259

1493

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

7.68

18.67

1.9

1.4

2.2

3.8

mg/l

0.64

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.68

18.67

1.9

1.4

2.0

2.9

mg/l

0.26

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

7.68

18.67

1.9

1.4

3.1

1.2

mg/l

0.55

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

7.68

18.67

1.9

1.4

1.0

0.9

mg/l

0.08

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.68

18.67

1.9

1.4

1.2

1.1

mg/l

0.08

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

7.68

18.67

1.9

1.4

2.5

2.1

mg/l

0.09

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.68

18.67

1.9

1.4

2.0

2.5

mg/l

0.18

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

7.68

18.67

1.9

1.4

0.9

1.3

mg/l

0.37

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.68

18.67

1.9

1.4

1.3

1.9

mg/l

0.25

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4014

37389

1.42

18.50

18.8

11.8

83.7

83.9

ml/min/173m2

0.27

3449

30752

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

110

4.30

18.49

1.2

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

524

3515

1.55

18.25

2.8

2.2

0.2

g/l

0.82

482

3295

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.96

18.21

1.4

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

282

1622

1.78

17.86

4.9

3.2

25.1

25.2

mmol/l

0.29

275

1565

(4035726)

497

3312

1.56

17.81

1.6

1.4

—

(3042631) Mycobacterium sp identified in Specimen

111

451

2.50

17.72

2.5

2.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

381

2.63

17.67

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

578

3998

1.51

17.42

7.6

7.3

5.0

5.1

kpa

0.92

554

3811

(3027801) Oxygen [Partial pressure] in Arterial blood

578

3998

1.51

17.42

7.6

7.3

12.1

12.5

kpa

1.29

555

3812

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

538

3671

1.52

17.29

3.0

2.4

35.2

51.6

u/l

0.67

467

3149

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4476

42711

1.60

17.24

15.1

9.7

26.4

26.0

u/l

0.54

4355

41306

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

900

6792

1.40

17.03

3.4

2.9

2.5

2.4

mmol/l

0.79

776

5955

(40761536) Microorganisms panel - Urine sediment

504

3402

1.54

17.02

5.1

3.8

—

(3003396) Base excess in Arterial blood by calculation

575

3992

1.50

17.00

7.6

7.3

1.1

mmol/l

0.14

439

3093

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.17

16.94

1.4

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

156

748

2.12

16.93

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

156

748

2.12

16.93

1.4

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

463

3071

1.56

16.91

7.0

3.6

1.2

mmol/l

3.18

427

2657

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

199

1043

1.95

16.90

2.0

10.0

11.1

mg/l

1.04

182

970

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

432

2823

1.58

16.84

2.3

16.2

23.9

au/ml

1.11

178

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

146

3.66

16.72

1.2

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

549

3788

1.51

16.71

4.7

3.1

—

(3016502) Oxygen saturation in Arterial blood

519

3548

1.52

16.51

7.9

7.7

95.4

95.8

0.70

506

3414

(3041096) Erythrocytes [Presence] in Urine by Automated

1330

10720

1.33

16.44

4.1

3.1

—

(3012501) Base excess in Blood by calculation

164

811

2.06

16.41

5.2

4.1

2.3

2.6

mmol/l

1.06

113

536

(3013290) Carbon dioxide [Partial pressure] in Blood

164

812

2.06

16.36

5.2

4.1

4.9

5.0

kpa

2.31

164

801

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

153

3.56

16.36

3.6

3.0

—

(40768804) Tissue Pathology biopsy report

1931

16391

1.30

16.32

2.2

2.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

796

5922

1.41

16.30

3.7

2.7

3.1

3.0

e6/l

0.12

440

3161

(3022806) Fractional oxyhemoglobin in Capillary blood

111

470

2.39

16.24

2.4

1.8

89.7

89.8

0.06

111

464

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

11.37

16.20

2.9

2.5

—

(3027315) Oxygen [Partial pressure] in Blood

164

817

2.04

16.09

5.2

4.2

9.0

8.6

kpa

1.24

164

805

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

105

4.12

16.04

1.2

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

184

962

1.95

15.76

1.6

1.4

8.5

15.6

iu/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2165

18708

1.28

15.72

5.0

3.9

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.22

15.66

1.3

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

104

4.06

15.39

1.2

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

3660

33881

1.32

15.27

24.8

15.6

13.8

13.6

6.71

3597

33160

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

142

684

2.11

15.26

1.7

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3017

27228

1.28

15.24

3.8

3.0

48.4

44.7

u/l

1.40

2854

25552

(3044640) Blood type and Crossmatch panel - Blood

1507

12474

1.30

15.12

3.1

2.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

926

7145

1.37

15.11

1.4

1.3

33.4

30.7

iu/ml

0.20

268

2269

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

307

2.67

14.96

2.1

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

307

2.67

14.96

2.1

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

307

2.67

14.96

2.1

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

3.90

14.91

1.2

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

107

465

2.33

14.80

7.0

6.6

11.7

11.6

mg/l

0.08

100

433

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

340

2166

1.61

14.72

1.7

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1300

1.78

14.62

3.2

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1300

1.78

14.62

3.2

2.3

3.9

3.8

g/l

0.30

172

939

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1301

1.78

14.58

3.2

2.3

7.3

7.4

g/l

0.47

179

981

(3003327) Ova and parasites identified in Stool by Light microscopy

236

1372

1.76

14.44

1.8

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

331

2107

1.61

14.38

5.3

3.2

127.0

129.3

g/l

1.09

323

2045

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

263

1578

1.70

14.38

4.4

2.8

0.7

0.80

253

1511

(3026389) Candida sp identified in Specimen by Organism specific culture

123

574

2.17

14.36

1.4

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

214

1213

1.80

14.27

3.3

2.3

10.2

10.3

g/l

0.10

186

1037

(3013005) Retinol [Moles/volume] in Serum or Plasma

173

3.20

14.20

1.8

2.1

1.9

umol/l

0.57

161

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

214

1220

1.79

14.01

3.3

2.4

3.1

g/l

0.20

174

963

(3044889) 12 lead EKG panel

2978

26968

1.27

13.95

4.1

3.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1021

8082

1.33

13.94

1.7

1.6

50457060.5

31239394.3

pmol/l

0.37

876

6796

(3012516) Albumin [Mass/volume] in Urine

1270

10373

1.30

13.84

3.9

3.2

340.9

365.1

mg/l

0.07

829

6462

(40761535) Cells panel - Urine sediment

448

3083

1.50

13.74

4.7

3.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

271

1661

1.67

13.69

1.3

1.2

2.1

1.1

u/ml

0.29

156

(3019060) Gas panel - Arterial blood

350

2285

1.57

13.67

5.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

265

1616

1.68

13.64

4.4

2.8

1.2

1.3

0.78

265

1600

(3037756) Immunofixation for Serum or Plasma

135

669

2.05

13.50

1.8

1.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

221

1286

1.75

13.49

2.4

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.22

13.41

1.3

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1381

11449

1.29

13.33

4.1

3.2

7.5

mmol/l

0.01

1190

9692

(40760888) Immunoglobulin light chains.free panel - Serum

148

762

1.97

13.31

4.5

3.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

200

1136

1.79

13.27

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

133

662

2.04

13.15

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

183

1018

1.83

13.01

4.4

3.3

61.1

112.9

mg/l

0.42

139

835

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

194

1100

1.80

12.95

3.9

2.3

1.6

0.8

g/l

1.28

176

965

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

277

1732

1.64

12.95

6.9

4.4

24.1

mmol/l

0.01

250

1565

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

100

3.82

12.86

1.2

1.1

—

(3010421) pH of Blood

175

965

1.84

12.80

5.2

4.0

7.4

0.42

165

800

(3024932) HLA-DR beta [Type]

119

3.55

12.79

1.3

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

207

1201

1.76

12.78

2.6

2.3

385.3

644.1

ug/l

0.68

192

1118

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

423

2920

1.49

12.76

2.3

6.5

6.7

ug/l

0.04

356

2565

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1159

9439

1.30

12.73

2.8

2.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

123

603

2.07

12.68

2.2

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

196

2.93

12.68

1.6

1.3

82.5

65.3

1.19

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

182

1019

1.82

12.68

4.4

3.3

55.2

60.0

mg/l

0.08

137

837

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

120

3.52

12.63

1.6

1.1

14.4

19.3

0.23

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

176

980

1.83

12.48

3.4

2.2

0.0

g/l

0.43

167

908

(3024471) HLA-A [Type]

121

3.49

12.48

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

155

829

1.90

12.48

1.5

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

204

1190

1.75

12.37

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

205

1198

1.74

12.35

1.3

1.2

—

(40761511) CBC panel - Blood by Automated count

4402

42240

1.44

12.35

18.8

12.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

341

2270

1.54

12.22

5.5

3.5

5.1

5.2

kpa

1.52

318

2116

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

165

907

1.85

12.21

3.5

2.3

0.0

g/l

0.00

156

846

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

166

915

1.84

12.17

3.5

2.3

0.0

g/l

0.00

157

847

(3000093) Morphology [Interpretation] in Blood Narrative

328

2.43

12.17

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

215

1279

1.71

12.16

1.6

0.1

5.4

iu/ml

0.62

271

(3009343) pH of Capillary blood

337

2244

1.54

12.06

5.5

3.5

7.4

2.66

270

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

201

1178

1.74

12.00

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

450

2.20

11.97

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

180

1023

1.79

11.95

3.3

2.2

37.5

37.8

g/l

0.28

163

888

(3002173) Hemoglobin [Mass/volume] in Arterial blood

462

3288

1.45

11.91

8.5

8.1

119.7

121.9

g/l

1.61

451

3165

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

318

2097

1.55

11.89

1.8

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

175

989

1.80

11.84

4.2

3.2

1.9

2.1

ratio

0.12

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

229

2.68

11.57

1.2

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

857

6779

1.32

11.52

1.4

1.3

12.4

11.3

u/ml

0.16

321

2734

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

153

837

1.85

11.51

1.3

1.2

1.8

3.0

u/ml

0.37

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

325

2171

1.53

11.47

5.5

3.5

1.3

1.8

mmol/l

1.51

249

1621

(3023183) Ammonium ion [Moles/volume] in Plasma

141

753

1.90

11.43

3.8

2.8

38.5

35.6

umol/l

0.52

126

645

(3020682) Albumin/Creatinine [Ratio] in Urine

1306

10922

1.27

11.41

4.6

4.0

11.8

8.7

mg/mmol

0.99

860

6861

(3020891) Body temperature

229

1410

1.65

11.40

4.7

4.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

10.02

11.33

1.3

1.2

—

(4010399)

383

2659

1.48

11.23

1.5

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

101

482

2.12

11.22

2.2

1.7

384.0

1200.0

titre

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

196

1164

1.71

11.18

1.3

1.2

22.8

38.5

u/ml

0.64

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

127

662

1.94

11.08

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

100

478

2.11

11.07

2.3

2.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

183

1071

1.74

11.01

1.3

1.1

—

(3042733) HLA Ab [Presence] in Serum

112

3.41

10.94

5.4

4.9

—

(40757373) Influenza virus identified in Isolate

3.99

10.47

1.7

1.5

—

(3019150) Specific gravity of Urine by Refractometry

1036

8499

1.28

10.47

4.8

3.9

1.0

kg/l

0.11

142

1294

(3039162) Centromere protein B Ab [Units/volume] in Serum

101

496

2.06

10.44

1.4

1.3

73.2

42.4

u/ml

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

425

3052

1.43

10.43

2.8

2.5

61.2

68.4

ml/min/173m2

3.22

194

1192

(3013512) EKG study

1256

10550

1.26

10.41

4.3

3.6

—

(3000012) Reticulocyte production index

179

2.81

10.41

1.6

1.5

—

(3036489) Thrombin time

231

1464

1.61

10.27

2.6

2.2

21.6

21.3

0.21

203

1253

(3052851) Hemolysis interference index of Serum or Plasma

186

1119

1.69

10.15

3.3

3.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.71

10.12

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

178

1061

1.70

10.05

1.4

1.2

16.6

6.3

u/ml

0.51

110

(3037121) Protein [Mass/volume] in Urine

207

1284

1.64

10.05

4.8

3.1

0.5

0.3

g/l

0.43

116

522

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

153

875

1.77

10.00

1.3

1.2

24.8

45.5

u/ml

1.15

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

194

1189

1.66

9.87

1.4

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

323

2.28

9.82

3.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

648

5033

1.33

9.80

2.2

2.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

262

2.42

9.75

1.3

1.1

—

(1616796) Gas panel - Central venous blood

142

801

1.80

9.74

5.1

3.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

220

1403

1.59

9.55

2.2

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

183

1115

1.67

9.54

4.6

3.3

0.4

u/ml

0.07

111

644

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

178

1077

1.68

9.53

1.4

1.3

14.0

7.2

u/ml

0.57

173

(3000492) Spirometry study

510

3843

1.37

9.41

1.6

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

124

680

1.85

9.33

1.2

1.1

16.7

12.6

au/ml

—

(3028626) Oxygen [Partial pressure] in Capillary blood

144

828

1.76

9.27

6.4

3.3

8.5

8.3

kpa

0.48

138

768

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

197

2.61

9.22

1.3

86.7

67.8

titre

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

186

2.65

9.17

2.3

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

186

2.65

9.17

2.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

186

2.65

9.17

2.3

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

186

2.65

9.17

2.3

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.31

9.15

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

270

2.35

9.14

1.4

1.2

—

(3021901) Oxygen saturation in Capillary blood

115

620

1.88

9.14

3.3

2.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.27

9.11

1.3

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

142

2.90

9.10

1.1

475.4

369.8

ng/l

0.12

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

181

1114

1.65

9.09

3.2

2.7

187.2

184.7

0.14

172

1063

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

273

2.32

8.93

1.4

1.2

—

(3007461) Platelets [#/volume] in Blood

4622

45066

1.51

8.91

30.7

19.1

255.0

256.2

e9/l

0.53

4532

44012

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

706

5623

1.30

8.86

2.2

2.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

274

2.32

8.86

1.1

1.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

315

2207

1.46

8.83

7.5

7.1

24.2

24.5

mmol/l

0.48

305

2050

(3010813) Leukocytes [#/volume] in Blood

4624

45099

1.51

8.79

30.6

19.1

6.8

6.7

e9/l

2.28

4528

43915

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.78

8.77

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

4624

45104

1.50

8.73

30.8

19.2

133.1

135.0

g/l

16.13

4571

44503

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.12

8.70

6.7

5.9

—

(3024731) MCV [Entitic volume]

4622

45086

1.50

8.67

30.5

19.0

91.1

90.7

6.09

4568

44494

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

109

3.13

8.63

1.3

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

4622

45093

1.50

8.58

30.6

19.0

4.4

4.5

e12/l

16.49

4525

43921

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

272

2.30

8.56

1.1

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

265

1806

1.49

8.55

9.7

9.3

24.1

24.3

mmol/l

0.60

243

1692

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

206

1332

1.57

8.47

1.4

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

385

2.07

8.41

4.3

4.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

177

1106

1.62

8.40

1.5

1.4

261.0

289.3

ug/g

1.07

105

611

(3035941) MCH [Entitic mass]

4620

45086

1.49

8.38

30.5

19.0

30.3

30.2

2.49

4566

44491

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

193

1237

1.58

8.25

3.0

2.4

93.7

92.5

0.29

181

1145

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

232

1551

1.52

8.22

2.5

1.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.31

8.05

1.3

—

(46236302) HLA-C [Type] by High resolution typing

7.87

7.99

1.0

—

(40760410) HLA-B [Type] by High resolution

7.87

7.99

1.0

—

(40760409) HLA-A [Type] by High resolution

7.87

7.99

1.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

144

866

1.68

7.95

4.0

3.1

24.2

25.0

mmol/l

1.53

130

756

(3006922) Hepatitis E virus Ab [Presence] in Serum

288

2.20

7.92

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

464

1.94

7.88

1.6

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

573

4506

1.31

7.88

23.0

22.8

1.3

inr

0.01

653

(40768446) Kidney Pathology biopsy report

143

2.74

7.85

2.4

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

465

1.93

7.83

1.6

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

591

4673

1.30

7.80

1.8

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

127

2.85

7.78

3.0

1.8

62.2

52.9

ug/l

0.30

121

(3005988) Vibrio sp identified in Specimen by Organism specific culture

467

1.92

7.74

1.6

1.4

—

(36660697) Celiac disease serology panel - Serum

444

3377

1.35

7.70

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

331

2.10

7.69

1.3

1.1

52.1

39.8

mg/l

1.14

278

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

478

1.90

7.56

1.6

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3757

35779

1.22

7.55

6.1

5.3

39.6

39.2

mmol/mol

1.67

3503

33325

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

152

2.65

7.53

2.3

2.0

—

(40768795) Lymph node Pathology biopsy report

363

2.03

7.41

1.4

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

371

2.01

7.35

3.6

3.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

191

2.42

7.24

1.1

1717.6

1454.7

miu/ml

0.66

191

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

307

2.10

7.17

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.93

7.15

1.1

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

209

1416

1.50

7.00

5.7

5.4

1.6

1.7

0.17

199

1319

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

471

1.86

6.93

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

473

1.85

6.84

1.6

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

150

949

1.60

6.84

1.4

—

(3021788) Differential panel - Synovial fluid

111

651

1.72

6.78

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

102

584

1.76

6.77

1.3

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

362

2723

1.36

6.77

3.3

3.4

4.4

4.5

pmol/l

0.73

321

2442

(3022313) Gas panel - Capillary blood

236

1651

1.45

6.73

5.9

3.6

—

(3013862) HLA-DP [Type]

7.16

6.69

1.0

—

(40763590) HLA-DQ beta [Type]

7.16

6.69

1.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

376

2855

1.34

6.61

3.7

2.9

166.7

186.0

ng/l

0.42

334

2581

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

181

2.39

6.60

9.0

6.0

44.6

59.2

u/ml

0.42

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1165

10108

1.20

6.59

1.7

1.6

1.5

1.4

mmol/l

1.63

994

8557

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

151

2.53

6.58

2.4

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

151

2.53

6.58

2.4

2.0

—

(3042517) Benzodiazepines panel - Urine

4.16

6.54

4.2

2.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.81

6.52

1.2

0.0

u/ml

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.81

6.52

1.1

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3982

38290

1.22

6.50

4.6

4.2

5.9

mmol/l

1.06

3677

35204

(3004716) Salmonella sp identified in Stool by Organism specific culture

304

2239

1.38

6.50

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

3.65

6.46

1.5

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

122

744

1.66

6.46

1.1

5.0

1.8

u/ml

0.73

185

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

4.56

6.45

4.9

2.4

0.9

1.3

mg/l

0.59

(3035637) Corticotropin [Mass/volume] in Plasma

490

1.81

6.43

2.0

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.22

6.28

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.25

6.27

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.25

6.27

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.25

6.27

1.3

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

167

1107

1.53

6.24

1.3

1.2

120.6

115.2

titre

0.04

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

304

2.02

6.22

1.2

563.8

193.5

titre

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

577

1.73

6.21

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

203

1404

1.47

6.17

5.9

5.4

0.9

0.61

193

1311

(3008295) Osmolality of Serum or Plasma

390

1.89

6.10

1.2

1.4

279.9

279.2

mosm/kgh2o

0.11

300

(3003888) Timothy IgE Ab [Units/volume] in Serum

129

816

1.60

5.94

1.1

8.1

5.2

u/ml

0.88

422

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

147

2.46

5.93

2.6

3.2

9.2

7.8

mg/l

0.57

122

(3008401) Mugwort IgE Ab [Units/volume] in Serum

125

785

1.61

5.93

1.1

2.8

1.3

u/ml

0.63

335

(3002256) Pathology report gross observation

619

5089

1.25

5.91

1.3

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.01

5.89

2.6

3.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

422

3317

1.30

5.83

2.2

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

376

1.87

5.78

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

255

1863

1.39

5.75

11.6

10.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.61

5.75

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

259

2.06

5.73

1.3

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

116

722

1.62

5.72

4.9

2.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

329

1.93

5.66

1.5

31.9

32.8

0.06

205

(3004451) EKG impression Narrative

169

2.32

5.66

1.4

1.3

—

(3047181) Lactate [Moles/volume] in Blood

166

1125

1.49

5.62

6.7

6.4

1.2

1.3

mmol/l

0.18

150

987

(3051651) Icteric interference index of Serum or Plasma

221

2.14

5.62

4.0

3.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

134

868

1.56

5.59

1.7

17062.9

12316.8

e6/l

0.36

105

621

(4027681)

257

2.03

5.47

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

141

2.42

5.44

1.1

1.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

251

1847

1.38

5.44

3.6

2.7

0.3

e6/l

0.34

242

1788

(3018405) Lactate [Moles/volume] in Arterial blood

182

1267

1.45

5.40

3.8

3.9

1.4

mmol/l

0.18

182

1248

(3025130) Human papilloma virus identified in Specimen

103

633

1.64

5.36

1.6

1.7

—

(21494434) Karyotype in Bone marrow

301

1.94

5.33

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

461

3707

1.27

5.33

4.3

4.0

90.9

24.1

ug/l

0.46

371

2935

(3009542) Hematocrit [Volume Fraction] of Blood

3898

37577

1.19

5.32

20.7

13.8

39.4

39.8

2.53

2835

28121

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

203

1448

1.42

5.29

6.3

3.7

24.5

24.9

mmol/l

1.02

186

1353

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

331

1.88

5.25

3.3

2.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

390

3078

1.29

5.24

1.3

1.2

123.4

155.8

iu/ml

0.41

144

1170

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

3.48

5.16

1.0

0.2

0.1

u/ml

0.25

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

145

2.35

5.14

3.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

444

1.75

5.09

1.3

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

237

2.04

5.09

1.2

1.1

u/l

0.14

118

(3017354) Segmented neutrophils/100 leukocytes in Blood

342

1.85

5.08

4.5

3.5

59.1

57.5

0.16

226

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

293

1.92

5.05

1.9

1.3

3.1

1.0

u/ml

0.81

122

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

229

1682

1.38

5.04

1.1

—

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

101

629

1.62

5.02

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

205

2.11

5.00

1.4

1.2

nmol/l

0.22

164

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

136

908

1.51

4.99

1.2

1.1

3.1

1.4

u/ml

0.84

357

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

352

1.83

4.96

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.67

4.92

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

547

4529

1.23

4.89

1.5

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

100

2.61

4.88

1.7

1.9

56.5

47.2

u/l

0.10

(3011897) Casein IgE Ab [Units/volume] in Serum

2.99

4.82

1.4

1.3

52.9

0.9

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.07

4.78

1.2

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

9.01

4.78

5.3

2.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

9.01

4.78

5.3

2.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

120

788

1.54

4.77

2.5

2.2

125.5

129.1

g/l

0.75

575

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

172

1215

1.43

4.76

1.0

1.1

5.3

4.3

u/ml

0.14

161

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.28

4.74

1.0

1.1

66.7

53.2

0.63

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

332

2605

1.29

4.69

2.1

1.8

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.11

4.63

4.3

2.7

—

24.7

—

(3046861) Legionella sp Ag [Presence] in Urine

8.19

4.56

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.77

4.53

7.2

4.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.72

4.50

1.3

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

112

735

1.54

4.49

3.9

2.9

1.4

1.6

mmol/l

1.01

106

710

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.72

4.36

1.8

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

138

2.25

4.30

1.1

93.9

91.6

—

(3017569) Oxygen content in Arterial blood

171

2.11

4.27

2.1

2.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

393

1.71

4.24

5.7

6.1

6.9

7.3

mmol/l

0.53

330

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

152

2.18

4.23

1.4

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

152

2.18

4.23

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.56

4.21

1.3

1.2

—

(3011985) Renin [Units/volume] in Plasma

493

1.63

4.21

2.2

1.5

75.4

47.7

mu/l

0.37

436

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.14

4.20

1.5

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.62

4.20

1.1

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.62

4.20

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

167

1203

1.40

4.19

4.6

3.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.42

4.18

1.4

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

533

1.61

4.17

1.0

1.1

1.5

g/l

0.06

482

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

260

2009

1.31

4.15

2.6

2.2

7152.3

5621.3

u/l

0.29

105

782

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

134

2.25

4.14

1.1

1.2

94.8

91.8

—

(3017704) Immunofixation for Urine

188

2.03

4.07

1.7

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

131

908

1.45

4.07

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

105

696

1.52

4.06

1.2

1.1

—

(3008898) HLA-B27 [Presence]

209

1574

1.34

4.00

1.1

—

(3019225) pH of Specimen

447

3706

1.23

3.97

6.0

4.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

170

2.07

3.95

1.4

2.5

98.1

147.7

umol/l

0.70

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.64

3.92

1.1

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.72

3.91

1.6

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.89

3.89

1.7

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

104

696

1.51

3.86

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

427

1.65

3.86

1.6

51.4

58.4

0.76

269

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

140

2.15

3.76

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

164

1208

1.37

3.65

2.7

2.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

142

2.12

3.64

3.4

2.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.86

3.62

1.4

1.5

107.2

117.0

ng/l

0.16

(3003181) Sodium [Moles/volume] in Urine

601

1.52

3.62

1.3

1.4

66.3

65.0

mmol/l

0.12

485

(3028707) Methadone [Presence] in Urine by Screen method

112

773

1.46

3.60

4.0

3.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

329

1.71

3.58

1.2

1.4

69454.3

84233.3

e6/l

0.08

232

(1001926) Buprenorphine [Presence] in Urine by Screen method

184

1385

1.34

3.57

3.7

2.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.95

3.57

4.7

3.5

37.8

41.3

umol/l

0.27

(3047007) Chlamydophila sp Ab [Presence] in Serum

629

1.50

3.53

1.3

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

118

827

1.44

3.51

3.1

2.4

157.1

92.9

ug/min

0.84

498

(3034274) Bile acid [Moles/volume] in Serum --fasting

614

1.51

3.50

1.6

2.2

10.1

7.2

umol/l

0.29

444

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1016

9125

1.14

3.48

4.6

4.7

2.4

3.2

ug/l

0.84

915

8183

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

145

2.08

3.46

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

504

1.56

3.44

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

173

1.97

3.43

2.3

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

173

1.97

3.43

2.3

2.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

147

1077

1.38

3.40

4.2

3.8

3.9

mmol/l

0.48

140

1009

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.01

3.37

1.2

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.84

3.35

1.8

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

2.72

3.32

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.72

3.32

1.4

1.2

25.9

72.7

ng/l

—

(3016879) Cocaine [Presence] in Urine

212

1648

1.30

3.30

3.4

2.3

—

(3027008) Opiates [Presence] in Urine

228

1792

1.29

3.27

3.3

2.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

8.58

3.26

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

196

1511

1.31

3.25

1.2

1.3

197.1

226.2

miu/ml

0.53

726

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

256

1.76

3.24

1.0

1.1

1.8

6.3

nmol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

289

2345

1.25

3.19

1.4

1.3

28.2

iu/l

0.00

243

2008

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.86

3.18

1.2

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

6.37

3.18

1.0

—

(3028300) Cannabinoids [Presence] in Urine

228

1799

1.28

3.18

3.4

2.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

176

1342

1.32

3.17

1.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.31

3.16

1.3

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

869

7774

1.14

3.14

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

304

1.68

3.13

2.6

1.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

389

1.60

3.13

3.3

2.4

—

(3038515) Glucose [Moles/volume] in Venous blood

690

1.44

3.08

4.2

3.0

7.5

mmol/l

0.08

669

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.23

3.05

1.1

1.2

—

(3027944) Amphetamines [Presence] in Urine

223

1765

1.28

3.05

3.2

2.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

5.84

3.02

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

316

1.65

2.99

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

316

1.65

2.99

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

316

1.65

2.99

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

147

1.98

2.99

1.7

1.2

0.3

g/l

1.24

116

(3023430) Cat dander IgE Ab [Units/volume] in Serum

587

1.47

2.99

1.1

10.0

4.1

u/ml

1.22

232

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

10.01

2.98

1.0

—

(40768441) Liver Pathology biopsy report

286

1.69

2.97

1.6

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

531

1.50

2.96

1.1

4.3

0.3

u/ml

0.99

122

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

176

1.88

2.94

1.1

107.1

79.1

u/l

0.71

138

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

176

1.88

2.94

1.1

35.0

22.7

u/l

0.69

133

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

166

1271

1.32

2.93

4.1

3.5

163.1

4051.0

u/ml

1.06

139

1072

(3000764) Benzodiazepines [Presence] in Urine

224

1784

1.27

2.92

3.4

2.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

119

866

1.38

2.92

5.5

4.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

143

1072

1.34

2.91

1.9

2.0

3.6

4.5

iu/l

0.82

409

(3039000) Anion gap in Blood

109

782

1.40

2.91

8.4

7.6

11.7

11.2

mmol/l

0.74

100

697

(3016750) Collection duration of Urine

213

1.79

2.91

3.3

2.1

529.6

496.3

min

1.43

158

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

177

1.87

2.90

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.64

2.89

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.64

2.89

1.3

1.2

—

(3018572) Chloride [Moles/volume] in Blood

109

783

1.40

2.89

8.4

7.6

105.4

105.2

mmol/l

0.16

100

698

(3010838) Calcium [Moles/time] in 24 hour Urine

199

1.82

2.88

1.5

1.7

—

8.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

320

1.63

2.86

1.3

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

400

1.56

2.82

3.3

2.4

105.9

105.3

mmol/l

0.52

393

(3041354) Potassium [Moles/volume] in Venous blood

400

1.56

2.82

3.3

2.4

4.1

4.0

mmol/l

0.58

393

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

103

2.14

2.80

1.4

136.8

133.5

nmol/l

0.03

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.40

2.79

2.7

2.5

—

(3009871) Measles virus Ab [Titer] in Serum

137

1.98

2.79

1.7

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

2.86

2.74

1.4

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

138

1.96

2.74

1.1

0.2

2.2

u/ml

1.49

(3020393) Adenovirus Ag [Presence] in Stool

2.71

2.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

633

1.43

2.71

1.3

1.2

4.1

3.8

u/ml

0.06

217

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.24

2.70

1.5

0.3

0.4

ug/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

280

2310

1.23

2.69

1.1

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

461

1.50

2.69

1.3

1.4

304.1

291.7

pmol/l

0.12

359

(3010937) Rubella virus Ab [Presence] in Serum

3.75

2.67

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

280

1.65

2.66

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

374

1.56

2.66

1.1

1.2

55.2

59.3

u/l

0.24

257

(21494890) Protein electrophoresis panel - 24 hour Urine

327

1.60

2.65

3.2

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

126

1.99

2.65

1.4

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

147

1.91

2.64

6.8

6.1

66.0

72.7

mg/l

0.22

105

(4094501)

132

995

1.34

2.63

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

320

1.60

2.63

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

139

1057

1.32

2.61

1.4

1.3

—

(3044941) Cell count panel - Synovial fluid

588

1.44

2.61

1.5

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

339

3997

0.84

2.59

1.8

1.7

—

(3004775) Volume in Urine collected for unspecified duration

283

1.63

2.57

3.0

2.2

783.6

627.6

2.09

193

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

7.15

2.55

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

5.46

2.54

1.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

5.46

2.54

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.03

2.52

2.0

3.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

643

1.41

2.51

1.1

13.2

2.9

u/ml

2.73

243

(3012441) Differential panel - Pleural fluid

332

1.57

2.51

1.6

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

469

1.48

2.50

1.4

1.3

—

nmol/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

333

1.57

2.48

1.2

1.3

1.5

nmol/l

0.00

301

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.47

2.48

1.2

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4077

39945

1.13

2.47

5.0

4.5

2.8

mmol/l

3.82

3790

37065

(3045414) Leukocytes [Presence] in Urine

220

1789

1.24

2.45

2.1

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

188

1.76

2.44

1.9

2.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

166

1.81

2.44

1.6

1.5

2.7

4.0

—

(3045424) Erythrocytes [Presence] in Urine

664

1.39

2.43

1.7

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.95

2.41

1.3

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

531

1.44

2.41

1.5

1.3

0.1

0.4

nmol/l

—

(3019977) pH of Arterial blood

189

1.75

2.40

2.6

2.9

7.4

0.01

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

194

1560

1.25

2.39

1.6

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

107

794

1.36

2.39

1.7

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

281

1.61

2.39

1.1

30.1

1.0

u/ml

0.69

(40765096) Chromosome analysis panel by Banding

118

1.95

2.35

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

100

737

1.36

2.34

4.0

3.4

272.1

686.6

u/ml

0.49

679

(3005011) Chlamydia sp Ab [Titer] in Serum

2.31

1.5

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

612

1.40

2.30

1.3

3.1

4.6

u/ml

1.24

263

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

207

1.70

2.29

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

4.62

2.27

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

488

1.44

2.26

1.5

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

349

1.52

2.26

1.5

10006.7

80682.3

e6/l

2.38

214

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

439

1.46

2.25

2.2

31.2

22.0

mg/l

0.64

108

(3036603) Volume of Urine

239

1.64

2.25

1.6

1.4

1598.8

2031.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

201

1.70

2.24

2.3

2.5

84.7

31.1

umol/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.56

2.21

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

283

2389

1.20

2.20

2.4

2.1

12.2

nmol/l

0.01

235

2102

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

2.62

2.18

2.5

1.9

2.0

1.4

mg/l

0.56

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.24

2.17

2.0

2.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

136

1.84

2.17

1.1

1.0

27.8

4.8

u/ml

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

4.29

2.15

1.0

—

(3007463) Buprenorphine [Presence] in Urine

3.69

2.15

22.0

5.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

108

1.95

2.15

1.7

1.6

5.9

3.5

0.41

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4010

39324

1.11

2.13

4.6

4.1

4.7

mmol/l

2.95

3753

36731

(3009466) Valproate [Moles/volume] in Serum or Plasma

570

1.39

2.13

4.7

5.4

332.4

371.4

umol/l

1.57

493

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

174

1.73

2.12

1.5

1.6

9.3

7.1

nmol/l

0.12

137

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

127

986

1.30

2.12

1.4

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

130

1.85

2.12

3.6

2.6

34.6

28.7

umol/l

0.70

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

103

777

1.33

2.11

2.7

2.1

0.8

nmol/l

0.51

653

(3024928) Oxygen saturation in Venous blood

100

752

1.34

2.09

6.2

3.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

268

1.57

2.08

1.7

1.5

—

(3016038) Potassium [Moles/volume] in Urine

229

1.62

2.07

1.2

30.2

34.7

mmol/l

0.58

200

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

254

1.58

2.03

1.4

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

2.01

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

435

1.43

1.98

1.7

1.5

32.4

32.8

g/l

0.09

393

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3845

37666

1.10

1.97

4.2

3.7

1.3

mmol/l

3.15

3574

34819

(3017315) Amylase [Enzymatic activity/volume] in Urine

186

1.67

1.97

1.2

1.3

222.9

304.6

u/l

0.62

172

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

517

4616

1.13

1.96

9.9

6.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3980

39055

1.10

1.96

4.5

4.1

1.5

mmol/l

1.00

3710

36315

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

225

1.60

1.96

1.6

11.9

5.7

u/l

0.82

114

(21494755) Public health laboratory ask at order entry panel

385

4385

0.87

1.96

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.75

1.93

1.0

1.3

—

(44813793)

290

1.52

1.92

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

339

1.48

1.91

1.5

1.3

—

titre

—

(21491868) Cryoglobulin [Mass/volume] in Serum

150

1.74

1.90

1.3

1.2

—

0.3

g/l

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.03

1.85

1.0

1.1

0.7

umol/24h

—

(3036071) Salmonella sp Ab [Titer] in Serum

152

1.71

1.83

1.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.17

1.82

5.8

3.8

—

(3006653) Thiamine [Moles/volume] in Blood

206

1.61

1.82

1.3

1.4

135.7

131.7

nmol/l

0.15

206

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

792

7281

1.10

1.81

4.0

4.1

22.1

21.6

0.43

359

3401

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

191

1.63

1.80

1.0

1.1

29.3

6.4

u/ml

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

232

1965

1.19

1.79

2.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.76

1.79

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

280

1.50

1.76

1.1

8.3

0.9

u/ml

0.53

(3021387) Prolactin [Units/volume] in Serum or Plasma

199

1666

1.20

1.75

1.7

1.6

273.5

295.7

mu/l

0.79

176

1494

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

177

1.64

1.75

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

309

2686

1.16

1.75

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

305

1.48

1.74

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.34

1.74

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

2.50

1.74

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.67

1.72

1.6

1.7

46.4

44.3

umol/l

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.85

1.71

1.2

1.0

—

(3000330) Specific gravity of Urine by Test strip

221

1873

1.19

1.71

4.4

3.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

103

1.85

1.71

1.2

1.4

16.7

17.2

umol/l

0.26

(1002224) Polysomnography panel

200

1680

1.20

1.71

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.29

1.70

1.5

1.7

4.6

7.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

647

1.32

1.70

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

133

1.73

1.69

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

251

1.52

1.67

1.8

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

219

1.56

1.67

1.2

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.16

1.66

1.0

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.80

1.65

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.80

1.65

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.03

1.64

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.93

1.64

1.1

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

557

5057

1.11

1.63

1.9

1.7

1.5

1.4

1.15

494

4504

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

183

1533

1.20

1.63

1.8

1.9

—

(3003694) ABO and Rh group [Type] in Blood

1235

11638

1.08

1.62

1.6

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.57

1.61

1.2

1.8

—

(3029075) Extractable nuclear Ab panel - Serum

113

1.77

1.60

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.50

1.59

1.3

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

214

1.55

1.59

1.4

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.00

1.59

2.1

2.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

159

1.64

1.58

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

159

1.64

1.58

1.2

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.00

1.58

1.0

2.0

—

(3017732) Neutrophils [#/volume] in Blood

323

2842

1.15

1.57

2.9

2.7

4.2

4.1

e9/l

0.31

259

2275

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

215

1.54

1.56

1.2

1.3

—

(40758292) HTLV I+II Ab panel - Serum

2.03

1.54

1.5

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

450

1.36

1.52

1.2

1.3

—

37.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.34

1.52

6.2

5.8

677.2

406.5

umol/l

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.59

1.51

2.6

2.2

2.7

3.0

mg/l

—

(3022621) pH of Urine by Test strip

295

2591

1.15

1.49

3.0

2.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.90

1.49

1.3

1.1

—

(3045788) Cell count panel - Pleural fluid

309

1.43

1.47

1.6

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

788

1.26

1.45

1.6

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

285

1.44

1.45

2.1

2.0

1.6

1.8

u/field

0.11

123

(3009214) Lutropin [Units/volume] in Serum or Plasma

146

1213

1.21

1.45

1.5

1.3

11.6

10.6

u/l

0.32

112

998

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.73

1.43

3.0

1.4

22.1

30.7

pmol/l

—

(4306422)

639

1.29

1.43

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

236

2711

0.86

1.42

1.4

—

(4034850)

155

1299

1.20

1.41

9.6

9.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

246

1.47

1.39

1.1

1.0

0.5

3.2

u/ml

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.94

1.38

1.6

1.7

—

(40762365) Oxygen content in Arterial blood by calculation

2.00

1.38

2.2

2.6

14.2

14.9

ml/dl

0.44

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

119

1.68

1.37

1.6

1.5

10.1

8.4

ug/l

0.51

119

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

166

1.57

1.37

2.6

2.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

268

2357

1.15

1.35

2.7

3.2

41.9

54.7

u/ml

0.55

260

2274

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

521

4768

1.10

1.34

1.8

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

232

1.47

1.33

1.6

5.1

6.8

u/l

1.20

200

(3017509) Phencyclidine [Presence] in Urine

2.14

1.33

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

524

1.30

1.31

1.1

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.10

1.30

1.1

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.78

1.28

2.8

3.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.89

1.28

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.05

1.26

1.7

1.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

130

1.62

1.26

1.6

1.5

53.8

62.2

0.48

110

(3023199) Leukocytes [#/volume] in Pleural fluid

397

1.34

1.25

1.6

1.5

1724.8

2170.5

e6/l

0.28

295

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.74

1.24

1.3

1.5

13.1

13.0

g/l

0.02

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.00

1.23

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.04

1.22

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

2.16

1.21

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.83

1.19

1.2

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.11

1.18

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

613

1.26

1.18

1.1

123.4

117.5

0.91

556

(4268621)

419

1.32

1.17

2.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

679

1.24

1.14

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

224

1.43

1.14

2.8

3.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

716

1.23

1.13

1.4

0.3

0.4

nmol/l

2.41

569

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

370

1.33

1.12

1.5

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.96

1.11

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.26

1.10

3.1

2.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

176

1.48

1.10

1.1

190.7

183.4

iu/ml

0.06

176

(3020491) Glucose [Moles/volume] in Blood

294

1.36

1.09

1.5

1.9

6.3

6.6

mmol/l

0.39

197

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.38

1.09

1.0

2.0

—

(3035880) pH of Pleural fluid

185

1.46

1.08

1.2

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

253

1.39

1.06

1.5

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

650

1.23

1.05

1.0

1.1

2.9

3.4

u/ml

0.20

314

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.27

1.03

1.2

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.27

1.03

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.02

1.1

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.92

1.02

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

171

1.46

1.02

1.7

2.1

15.4

169.9

ug/min

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

206

1.41

0.98

1.3

1.9

—

(4024509)

370

1.30

0.98

1.5

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

156

1.48

0.98

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.18

0.98

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

160

0.56

0.97

1.3

2.3

105.7

154.0

nmol/l

—

143

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.95

0.97

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

100

1.60

0.96

1.1

1.2

38.6

37.6

g/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

697

1.21

0.93

1.3

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.22

0.93

2.0

2.3

—

23.9

—

(4198724)

192

1.41

0.92

1.8

4.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.14

0.91

1.7

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

188

1669

1.13

0.90

1.4

—

(3048879) Bone marrow aspiration report

1.60

0.90

1.4

2.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.91

0.88

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

129

0.54

0.87

3.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.86

0.87

1.4

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

229

0.65

0.87

1.0

804.1

710.8

ng/l

—

153

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

273

1.32

0.85

1.1

4.8

9.6

iu/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.63

0.84

1.5

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

569

1.22

0.84

1.5

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

607

1.21

0.82

3.1

3.0

0.8

nmol/l

0.28

451

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.65

0.81

1.5

1.3

—

(40768806) Pleura Pathology biopsy report

346

1.27

0.81

1.5

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

112

969

1.16

0.80

1.9

1.7

36.9

41.4

nmol/l

0.95

112

938

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

147

1.43

0.80

1.1

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.67

0.78

32.1

12.3

4.5

5.9

mmol/l

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.67

0.78

12.3

9.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.77

0.76

2.8

2.6

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.77

0.76

1.0

1.1

—

1.1

u/ml

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

1.50

0.76

2.1

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

1.50

0.76

2.1

2.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

559

5276

1.07

0.75

2.9

0.7

0.8

ug/l

0.47

382

3378

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.08

0.74

1.0

1.1

—

(3003338) MCHC [Mass/volume]

3542

34986

1.05

0.72

26.1

16.4

332.1

332.4

g/l

0.70

3516

34718

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

230

0.69

0.72

1.0

33.9

46.8

ng/l

—

153

(3044009) aPTT.lupus sensitive (LA screen)

1.75

0.71

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

109

1.47

0.70

1.8

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

228

0.70

0.69

1.0

251.0

332.5

ng/l

—

155

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.53

0.68

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

1059

0.87

0.68

1.5

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

649

1.17

0.67

1.1

91.9

14458.4

iu/ml

0.53

162

(3047189) Immunofixation for 24 hour Urine

153

1.37

0.67

2.8

1.5

—

(3001729) Color of Synovial fluid

1.79

0.66

1.0

1.5

—

(3024263) Appearance of Synovial fluid

188

1.33

0.66

1.7

2.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

313

1.25

0.64

1.5

1.0

1.1

promille

0.27

240

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1064

0.87

0.64

1.6

1.4

—

(4015189)

1.50

0.63

1.6

2.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

442

1.20

0.62

1.2

1.1

99.1

95.9

0.38

418

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

173

1.33

0.61

3.1

2.3

55.3

53.5

umol/l

0.13

144

(3037556) Urate [Mass/volume] in Serum or Plasma

105

0.57

0.61

2.2

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.67

0.61

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

749

1.15

0.61

1.4

21.4

25.8

u/l

0.83

621

(3001019) Free T4 and TSH panel - Serum or Plasma

232

2513

0.92

0.61

1.8

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.60

0.61

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

346

0.78

0.61

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

401

0.80

0.60

1.5

1.6

7.4

7.7

mmol/l

0.17

248

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

1.5

—

18.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

140

1.36

0.58

2.4

2.5

—

(3011648) Oxygen content in Venous blood

300

1.24

0.58

2.9

3.2

11.7

11.2

0.36

300

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.46

0.58

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.46

0.58

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.46

0.58

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.46

0.58

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

419

1.20

0.57

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.48

0.57

1.4

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

115

1.39

0.56

1.4

2.1

989.1

20275.9

e6/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

115

1.39

0.56

1.9

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.62

0.55

1.3

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

117

1298

0.90

0.53

1.5

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.54

0.53

2.0

2.6

0.8

0.7

u/field

—

(1617658) Protocol used for examination of sentinel lymph nodes

338

0.80

0.52

1.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

117

1297

0.90

0.52

1.5

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.45

0.51

1.5

1.2

—

(3033799) Differential panel - Peritoneal fluid

109

1.38

0.50

1.8

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1094

0.89

0.50

1.6

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

121

1096

1.11

0.50

1.9

1.7

—

(3044927) Protein electrophoresis panel - Urine

335

1.20

0.48

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

271

1.22

0.48

1.2

1.1

1.0

ratio

0.40

(3032057) Clostridioides difficile [Presence] in Stool

1.45

0.48

1.9

2.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.43

0.46

3.7

2.8

—

(3034426) Prothrombin time (PT)

138

1.31

0.45

1.1

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

210

1.24

0.45

1.0

1.1

97.1

92.2

0.39

163

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

119

1303

0.91

0.44

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

119

1302

0.91

0.44

1.5

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

130

1.31

0.43

1.6

2.3

687.8

740.7

e6/l

0.04

(44806071)

1.43

0.42

1.3

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.40

0.42

1.8

1.9

19.1

30.4

pmol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

584

0.87

0.41

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.52

0.41

1.0

1.2

—

(4212803)

1.52

0.41

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

102

928

1.10

0.41

2.5

2.1

—

(3022670) pH of Venous cord blood

0.00

0.41

0.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

130

1409

0.92

0.40

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.47

0.40

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.41

0.39

1.1

1.4

—

112.3

—

(4038314)

0.00

0.39

0.0

1.2

—

(3006270) Folate [Moles/volume] in Blood

335

1.17

0.38

1.1

370.5

382.1

nmol/l

0.12

299

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.39

0.38

4.8

9.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

561

1.12

0.38

1.2

26.6

39.0

u/l

0.83

487

(3051593) INR in Capillary blood by Coagulation assay

158

0.76

0.37

14.4

11.3

—

(3003129) Base excess in Capillary blood by calculation

1.36

0.36

1.4

1.9

0.1

1.3

mmol/l

0.46

(3050129) First trimester maternal screen panel - Serum or Plasma

175

1642

1.07

0.36

1.5

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.33

0.35

1.8

2.0

14.7

17.2

umol/l

0.49

(3035320) C reactive protein [Mass/volume] in Body fluid

282

1.17

0.35

3.2

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.40

0.35

1.8

2.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

604

1.11

0.34

1.3

1.4

7.1

7.2

mmol/l

0.09

445

(3025018) Bordetella pertussis Ab [Titer] in Serum

255

1.18

0.34

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.34

0.34

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

220

0.82

0.32

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.30

0.30

4.3

2.6

—

(4281824)

441

0.88

0.29

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.25

0.29

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

185

1.19

0.29

2.0

1.8

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.23

0.29

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1459

14812

0.98

0.28

2.9

2.6

—

(3006462) Nitrate [Presence] in Urine

176

1.19

0.28

2.0

3.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

834

1.08

0.28

4.7

3.4

31.0

26.2

mg/l

0.52

507

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.68

0.26

8.8

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.68

0.26

4.4

3.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

126

0.79

0.24

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

100

939

1.07

0.23

1.6

1.5

—

(4146454)

360

1.11

0.23

2.9

2.7

—

(3022689) Creatine [Moles/volume] in Urine

106

1.23

0.23

1.7

1.4

—

(44806420)

1.25

0.22

1.5

2.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.25

0.22

1.2

1.1

446.2

286.8

pmol/l

0.35

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

258

2491

1.04

0.22

1.7

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.19

0.21

1.0

1.1

1.6

umol/24h

—

(3019174) dRVVT (LA screen)

1.19

0.21

1.2

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.21

0.0

2.8

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

2.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(4133840)

102

0.78

0.21

1.1

1.2

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.1

—

13.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

171

1640

1.04

0.20

1.5

—

(3014271) Vancomycin [Susceptibility]

164

1.16

0.20

3.8

2.9

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.25

0.20

1.8

2.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

170

1633

1.04

0.19

1.9

1.7

4.1

3.6

mg/l

0.20

123

1146

(3035933) Granulocytes/100 leukocytes in Blood

137

1.17

0.18

1.9

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

1.19

0.18

4.0

7.2

—

(4211845)

196

1.12

0.16

2.0

3.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

275

0.91

0.14

6.4

6.6

—

(40768793) Breast Pathology biopsy report

103

997

1.03

0.10

1.2

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

208

0.91

0.10

1.1

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.06

0.09

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

174

1.09

0.09

1.3

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

466

4610

1.01

0.08

4.6

4.2

32.4

32.5

0.07

336

3162

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.84

0.07

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

643

1.03

0.05

1.2

1.4

2.3

4.2

ug/l

3.02

581

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

564

1.03

0.05

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

181

0.94

0.05

2.3

1.6

—

(40768800) Prostate Pathology biopsy report

545

1.03

0.04

1.2

—

(3015183) Erythrocyte sedimentation rate

229

1.05

0.04

1.0

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

362

0.97

0.04

1.3

1.4

9.5

12.1

mmol/l

1.86

(3005082) Progesterone [Moles/volume] in Serum or Plasma

269

1.04

0.04

1.3

31.5

32.0

nmol/l

0.04

239

(3019897) Erythrocyte distribution width [Ratio] by Automated count

592

0.98

0.03

3.5

2.5

13.3

13.1

0.25

586

(43055514) Macroprolactin [Presence] in Serum or Plasma

112

1.07

0.03

1.3

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

132

1.06

0.02

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

122

1233

0.99

0.02

1.6

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

428

0.98

0.01

4.5

4.8

346.3

69.7

u/ml

0.38

126

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

247

0.97

0.01

1.5

1.4

140.9

171.9

pmol/l

—

(3000034) Microalbumin [Mass/volume] in Urine

342

0.99

0.00

2.9

64.2

36.5

mg/l

0.38

250

(3044007) Cell count panel - Peritoneal fluid

107

1.03

0.00

1.5

2.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.7

—

2.5

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.00

0.00

1.2

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.00

0.00

21.0

7.8

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

123.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

4.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.97

0.00

21.4

8.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.3

—

31.9

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.95

0.00

7.7

7.2

71.1

71.3

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

70.6

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

214.5

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

164.4

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.96

0.00

3.8

2.3

55.9

82.5

pmol/l

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

6.5

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.5

—

3462.8

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_HERPES_SIMPLEX and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_HERPES_SIMPLEX	1.414 [1.26, 1.59]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.132

During the follow-up period (1.1.1998 — 31.12.2019), 2089 out of 15898 females with AB1_HERPES_SIMPLEX died.

Males

Parameter	HR [95% CI]	p-value
AB1_HERPES_SIMPLEX	1.583 [1.4, 1.78]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 1872 out of 10705 males with AB1_HERPES_SIMPLEX died.

Mortality risk

Mortality risk for people of age

years, who have AB1_HERPES_SIMPLEX.

N-year risk	Females	Males
1	0.134%	0.29%
5	0.861%	1.828%
10	2.098%	4.349%
15	3.939%	8.385%
20	6.991%	13.889%

Relationships between endpoints

↥

Index endpoint: AB1_HERPES_SIMPLEX – Herpesviral [herpes simplex] infections

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Herpesviral [herpes simplex] infections

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints